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ABSTRACT 
 
Dinitrosyl iron complexes (DNICs), as well as S-nitrosothiols (RSNOs), form 
endogenously to provide a stable means of storage and transport for the highly reactive 
signaling molecule, nitric oxide. Through the development of biomimetic complexes, the 
fundamental chemistry of such DNICs is established within a range of ligand sets as 
anionic and neutral donors that stabilize the dinitrosyl iron unit, DNIU, in oxidized 
{Fe(NO)2}
9 and reduced {Fe(NO)2}
10 (Enemark-Feltham notation) redox levels. This 
amorphous electronic characteristic is readily accommodated by amino acid residues, 
cysteinyl S- and histidine N-donors, and their surrogates, as ligands to iron. My research 
targets a greater understanding of DNIC reactivity with components of cellular 
environments, the possible connections between the electronically similar d9, Cu(II) and 
d10, Cu(I), redox couple, the DNIC/Copper/RSNO connections, structural studies of 
aggregates of DNICs with metallodithiolates, as well as design strategies for NO-release 
therapeutic development of DNICs.  
A stable, reduced, {Fe(NO)2}
10 DNIC containing a bipyridyl ligand, 
[(neo)Fe(NO)2] (neo = 2,9-dimethyl-1,10-phenanthroline) was used to explore redox 
switches and N2 ligand exchange between copper and the Fe(NO)2. Both Cu
I and CuII 
sources were found to promote neo ligand transfer from the DNIU with concomitant NO 
release. With CuII, redox processes were also involved, as evidenced by the formation of 
a mixture of oxidized {Fe(NO)2}
9 DNICs, in addition to both CuI- and CuII-neo 
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complexes. Copper is known to catalyze the release of NO from RSNOs, and our 
discoveries found here are the first biomimetic investigation of copper’s reactivity with 
DNICs. 
 Reaction of an RSNO with reduced, {Fe(NO)2}
10 DNICs, [(L)2Fe(NO)2] (L = CO 
or neo), results in NO release and the formation of a unique (-S)(SR)2[Fe(NO)2]4 
cluster, containing an interstitial sulfide. Such a cluster can be visualized as a plausible 
intermediate in the known conversion of DNICs to FeS clusters. The NO released 
showed complete scrambling with 15N-labeled RSNO.  
 Although DNICs are promising NO-delivery candidates, the lack of 
biocompatible examples has hindered their development into useful therapeutics. We 
reported the first DNICs with pendant thiosugars, isolated in both monomeric and 
dimeric form. Cytotoxicity towards endothelial cells was low and steady NO release 
over several hours was observed in aqueous media.   
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
Nitric Oxide: the Essential Free Radical 
The area of nitric oxide chemistry has exploded in the thirty years since Ignarro, 
Furchgott, and Murad made the Nobel Prize winning discovery that nitric oxide was 
actually the endothelial-derived relaxing factor responsible for vascular relaxation in 
smooth muscle cells.1 Since that time, we have learned that in addition to vascular 
relaxation, endogenous nitric oxide also plays a seminal role in other essential biological 
processes including platelet aggregation and adhesion, the immune response to infection 
and wound repair.2 Additionally, NO is also involved in cancer biology and pathology, 
serving as a “two-edged sword” in which low concentrations of NO actually promote 
cell growth, whereas higher concentrations induce apoptosis.2 
The fundamental basis of understanding how living organisms use NO involves 
triggers for regulation of its biosynthesis. Nitric oxide is generated in vivo via a five-
electron oxidation of L-arginine to L-citrulline, catalyzed by the nitric oxide synthase 
(NOS) (Figure I-1).3  
2 
 
 
 
 
 
 
 
This family of heme-containing enzymes exists in three isoforms, namely 
neuronal (nNOS), endothelial (eNOS), and inducible (iNOS), each of which is encoded 
by a separate gene. These three isoforms can be classified into two broad classes of NOS 
based on the concentration of NO produced. Both nNOS and eNOS produce low 
concentrations of NO and are associated with signaling functions. The nNOS is 
responsible for cell communication and is expressed in both nerve cells and skeletal 
muscle, while eNOS is located in the endothelium and is responsible for vasodilation. 
The iNOS, on the other hand, catalyzes the production of large amounts of NO in 
response to immune system triggers, thus acting as an integral part of the immune 
Figure I-1. Nitric oxide synthase (NOS) catalyzes the NADPH-dependent 
conversion of L-arginine to L-citrulline, in the process producing nitric oxide. The 
NOS exists in three different isoforms (shown in the boxes) each of which fulfills 
specific and distinct functions.  
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system.4 From this, it can be seen that the concentration of NO released determines its 
function. At concentrations in the picomolar to low nanomolar range, NO plays a 
protective role. However, at concentrations above 400 nanomolar, its cytotoxic and 
regulatory effects predominate.5 This concentration dependent function is displayed in 
Figure I-2.6 As a reactive, free radical species, NO must be highly regulated and cannot 
be recognized by proteins via the weak intermolecular interactions that typify the 
recognition of other secondary messengers.7 Hence, NO signals primarily by binding to 
the ferrous heme of soluble guanylate cyclase, an entirely novel signaling mechanism at 
the time of its discovery.7 Additionally, because of the highly reactive nature of NO, it is 
tightly regulated with a lifetime of no more than 2 s as a free molecule in the biological 
milieu. 
Thus, other forms of NO must exist to facilitate its storage and transport; these 
have been identified as S-nitrosothiols (RSNOs) and dinitrosyl iron complexes 
(DNICs).8 S-nitrosothiols form upon reaction of nitric oxide with thiols present in the 
plasma. In the cardiovascular system, RSNOs, as the carriers of NO, are responsible for 
promoting vasodilation, inhibiting platelet aggregation, and regulating Ca2+ channel 
function that influences myocyte contractility and electrophysiologic stability.9 The 
mechanism by which RSNOs release NO is discussed in detail in the section titled 
“RSNOs and the interplay of Cu and Fe in NO Release.”  
4 
 
 
 
 
 
 
 
Dinitrosyl Iron Compounds (DNICs): Discovery and Biological Presence 
Biological DNICs (Figure I-3) were discovered in the mid-1960s from their 
characteristic EPR signal with g ~ 2.03 that arises from a single tetrahedral iron center 
coordinated by two nitrosyl ligands and two thiol/thiolate ligands.10 These paramagnetic 
DNICs have been shown to exist in both protein-bound11 and low molecular weight 
Figure I-2. Nitric oxide can be described as a two-edged sword, depending upon 
concentration. As depicted above, at micromolar concentrations, NO induces DNA 
damage and cell death, while at lower nano- and picomolar concentrations, NO serves 
protective roles such as vasodilation or even as part of the immune system (right hand 
side). Images within this figure were adapted from Arginine Cardio. Science of Nitric 
Oxide-What Nitric Oxide does for the health and wellness of our cardiovascular 
system, according to Dr. Rainer Böger, M.D. 
https://www.argininecardio.com/science-of-nitric-oxide.php (access July 21, 2017).6 
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(LMW)12 forms; however, there is also evidence for the formation Roussin’s red ester 
type complexes as well as Roussin’s black salts upon exposure of iron sulfur clusters to 
NO.13,14 
 
 
 
 
 
 
 
 
As such, it is generally understood that these naturally occurring DNICs most 
likely contain thiol ligands, given the abundance of glutathione (GSH) present in the 
cell, coupled with the high affinity of thiol ligands for the dinitrosyl iron unit (DNIU). 
Many studies have been conducted to elucidate the mechanism of formation of DNICs, 
revealing that nitrosylation of both [2Fe-2S] and [4Fe-4S] clusters produce DNICs.15 In 
Figure I-3. Various forms of DNICs proposed to be present in biological systems. 
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addition, the LMW-DNICs are thought to form as a result of thiol ligand exchange with 
the protein-bound form.12  
Iron-sulfur cluster degradation is not the only pathway by which DNICs are 
formed. Work by Toledo et al.16 and Hickok et al.17 report that the chelatable iron pool 
(CIP) also plays a major role.17 The CIP is a small, dynamic reservoir of iron utilized in 
the movement of iron between cellular compartments and metalloproteins.16 Treatment 
of macrophages with NO resulted in DNIC formation with concentrations of DNIC 
equal to or greater than the concentration of the chelatable iron.17 Concurrent cell 
treatment with the metal chelator, desferrioxamine, resulted in no DNIC formation, 
confirming the source of iron in the DNICs formed when the chelator was not present 
was indeed the CIP.17 Evidence also exists for DNIC formation from the iron-catalyzed 
decomposition of RSNOs; this report will be discussed in detail in the section addressing 
RSNOs, vide infra.18 
Key to the mutual affinities of NO and iron are their electronic characteristics. 
Delocalization between the valence orbitals of iron and those of NO arises from similar 
energy levels between the Fe 3d and low-lying NO * orbitals, which renders oxidation 
state assignments for Fe ambiguous; the term “non-innocent’ ligand is epitomized by 
NO.19 In an attempt to avoid this ambiguity, Enemark and Feltham proposed a notation 
wherein the electronic structure is denoted as {Fe(NO)2}
n, where n refers to the number 
of d electrons plus the number of NO π* electrons.20 However, this notation simply 
avoids the issue of the actual electron distribution, especially in interpretation of 
spectroscopies that might reflect physical and reactivity properties. For a more explicit 
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description of electron distribution, computations and advanced spectroscopic techniques 
are needed.  
Synthetic Analogs  
The complexities of the biological environment render detailed cellular studies of 
DNICs extremely challenging. Hence chemists have built a library of synthetic DNICs in 
order to define spectroscopic signals, compare structures, and understand their chemical 
reactivity. As outlined in an extensive review by Liaw et al. DNICs can be categorized 
into two broad categories: mononuclear (including both the classical four-coordinate and 
non-classical five- and six-coordinate DNICs) and dinuclear (also referred to as 
Roussin’s red esters).21 The typical four-coordinate DNICs of general form 
[L2Fe(NO)2]
0/-1/-2 have been isolated in both redox levels and with a wide range of 
ligands, some examples of which are shown in Figure I-4.15,22-24  
 
 
 
 
 
 
 
 
π-acceptors                                         σ-donors                                             π-donors 
Figure I-4. Examples of DNICs that have been synthesized (1-5)15,22-24 that 
incorporate a range of donor ligands as well as different oxidation states 
{Fe(NO)2}
10 (1 and 2), both {Fe(NO)2}
10/9 (3/3+) and {Fe(NO)2}
9 (4 and 5). 
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The EPR active, oxidized {Fe(NO)2}
9 DNICs exist as both neutral and anionic 
species with S-, N-, O- and C-donor ligands.21 Liaw et al. have also investigated the 
exchange of biologically relevant S-, N-, O- and C-donor ligands with the {Fe(NO)2}
9, 
[X2Fe(NO)2]
-
 motif, finding the binding affinity to be thiolate (SR
−) > imidazolate (Im−) 
> phenolate (OPh−) > carboxylate (COO−) > nitrite (NO2
−) > nitrate (NO3
−).25 [We note 
that this order might not hold for DNICs in a biological system, considering that one of 
the glutathione ligands of the bis-glutathione DNIC is replaced by an active site tyrosine 
upon addition of the glutathione S-transferase (GST) to the bis-glutathione DNIC (See 
section on GST for further discussion)]. The EPR silent, reduced {Fe(NO)2}
10 DNICs, 
on the other hand, prefer the neutral N- and C-donor ligands, although there is at least 
one example of a dianionic DNIC in the {Fe(NO)2}
10 oxidation state where the Fe of the 
DNIU is coordinated by two ethanethiol ligands.21,26  
Mononuclear DNICs with expanded coordination numbers have only been 
isolated in the oxidized, {Fe(NO)2}
9 state with S-, N- and O-donor ligands, and adopt 
square pyramidal and trigonal bipyramidal geometries for the five-coordinate DNICs 
and octahedral geometry for the six-coordinate DNICs.27 For the dinuclear or Roussin’s 
red ester DNICs, the two DNIUs are bridged by S-donor (or in one case, O-donor) 
ligands and exist in the anitferromagnetically coupled, EPR silent, neutral [{Fe(NO)2}
9- 
{Fe(NO)2}
9] state, the anionic mixed valent, EPR active, [{Fe(NO)2}
9- {Fe(NO)2}
10] 
state, or the dianionic [{Fe(NO)2}
10- {Fe(NO)2}
10] state, which is EPR silent.28-30  
X-ray absorption spectroscopy, Fe/S K-edge XAS,25,30,31 and X-ray emission 
spectroscopy, valence to core (V2C) Fe K XES,32 supported by ab initio DFT 
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calculations, in addition to direct probing of the Fe-NO and N-O bond strengths through 
IR, resonance Raman and Nuclear Resonance Vibrational Spectroscopy studies, have 
provided more definitive insights into the Fe-NO bonds.11,33,34 The Fe K-edge XAS pre-
edge energies of various tetrahedral {Fe(NO)2}
9 DNICs were reported to be 
∼7113.4−7113.9 eV, placing them between the FeII and FeIII standards.35 On this basis, 
the electronic state of the {Fe(NO)2}
9 DNICs is assigned as a resonance hybrid of 
{FeII(•NO)(NO−)}9 and {FeIII(NO−)2}9 electronic states.35 Liaw et al. further report that 
ligation by hard O-containing ligands polarizes the {Fe(NO)2}
9 core to possess more 
{FeIII(NO−)2}
9 character that DNICs coordinated by soft S-containing ligands, as 
confirmed by both DFT calculations and a combination of S K-edge pre-edge and 
thiolate energy peaks.32 Furthermore, the reduced {Fe(NO)2}
10 DNICs are assigned as 
{FeII(NO−)2}
10 in which high spin FeII (S = 2) is antiferromagnetically coupled with two 
triplet NO− ligands.20,23 
All such studies highlight the Fe(NO)2 as a singular unit, with considerable 
covalency in the Fe-NO bond and likely quite resistant to NO exchange with classical 
two-electron donor, diatomic ligands such as CO or CN-. The next section reviews NO 
release from DNICs, factors that promote NO release, and assays that may be used to 
characterize the process. 
NO Release from DNICs  
With the numerous vital roles played by NO and the therapeutic potential for 
NO-bearing species, understanding the process of NO release is of great importance. 
Ford et al. have done outstanding work in this area by developing a water-soluble, dye-
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derivatized dimeric DNIC Fe2(-RS)2(NO)4 (RS = 2-thioethyl ester of fluorescein) that 
uses both single and two-photon excitation to sensitize NO release.36,37 As measured by 
an NO electrode, Fe2(-RS)2(NO)4 releases ~3.2 mol of NO per mol of compound.37 
Although this is a promising strategy for NO therapy, the applications are limited to sites 
that are readily penetrated by the light source. Additionally, the use of light to promote 
NO release fails to explain the transfer of NO from naturally occurring DNICs within a 
biological system. The following section will review those studies that have examined 
other stimuli to encourage NO release/transfer from DNICs. 
Considering the importance of understanding the mechanism for NO release 
from DNICs, surprisingly few studies have been devoted to this area of DNIC chemistry. 
Table I-1 summarizes the studies that have examined NO release from DNICs. A 
structure of the DNIC used in each study, along with the NO trapping agent and the 
stimuli used to induce NO release are provided in the table. Most of the NO release 
studies reported to date utilize an NO-trapping agent to promote transfer of NO from the 
DNIC. In 2006, the M. Y. Darensbourg laboratory reported NO transfer from a unique 
dithiolate DNIC to an iron porphyrin, entry 1, Table I-1.38 Even when performed in the 
dark, NO transfer still occurred, suggesting that the associative process could derive 
from either protonation from the ligand or through a bimolecular interaction of the two 
reagents.38 Additionally, the rate dependence on acid implies that NO is transferred to 
the FeIII porphyrin as HNO. This is one of the few studies that identified the iron product 
following removal of one NO. A role for protonation in NO release is also supported by 
work from Vanin et al. that demonstrated that acidic pH enhances the NO release rate.39 
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The M. Y. Darensbourg laboratory has carried out NO release studies with bis-N-
heterocyclic (NHC) DNICs.22 N-heterocyclic carbene ligands have become a standard of 
organometallic chemistry for their strong -donating capabilities and ability to bind to 
and stabilize a wide range of transition metal complexes.22 It should also be noted that 
the NHC can be viewed as a mimic for imidazole which in turn is a surrogate for 
histidine.40 The {Fe(NO)2}
9 NHC-DNICs were found to release (or transfer) NO in the 
presence of Co(TPP), while no NO release was observed for the {Fe(NO)2}
10 DNICs 
(entry 2, Table I-1). Clearly, with organometallic-like DNICs, oxidation leads to 
destabilization and NO release.   
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Table I-1. Summary of the DNICs that have been investigated for NO release, 
along with the promoter for the NO release.  
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In 2011, Lippard et al. also reported reductive nitrosylation of Fe(III)(TPP)Cl 
(where TPP = 5,10,15,20-Tetraphenyl 21H,23H-porphine) by an {Fe(NO)2}
9 DNIC 
[Fe(NO)2(Ar-nacnac)] (where Ar-nacnac = anion of [(2,6-
diisopropylphenyl)NC(Me)]2CH) with dissociation of either NO or NO
- (entries 3 and 4, 
Table I-1).41 When this DNIC is reduced to the {Fe(NO)2}
10 state, it displayed rapid 
electron transfer to the Fe(III)(TPP)Cl. The {Fe(NO)2}
9 DNIC resulting from the 
electron transfer then nitrosylated the Fe(II)(TPP).41  
Liaw et al. ventured from the use of porphyrins and showed that addition of 
different chelating ligands to a carbazolate DNIC triggers the release of either NO+, NO·, 
or NO-, depending upon the incoming substitution ligand (entry 5, Table I-1).42 
Following the idea that incoming substitution ligands promote NO release, biological 
studies have shown that the rate of NO release is dependent upon the free thiol 
concentration, with an increase in NO release in the presence of thiols.43 Additionally, 
Vanin et al. claim that the glutathione-DNIC only demonstrated NO release in the 
presence of iron chelators, suggesting that the chelator is needed to promote the NO 
release.44  
Kim et al. reported an interesting NO release strategy (entry 7, Table I-1) in 
which loss of the iodide from the stable five-coordinate DNIC [Fe(TMEDA)(NO)2I] 
generates the metastable {Fe(NO)2}
9 species [Fe(TMEDA)(NO)2]
+ that spontaneously 
decomposes and releases NO, as confirmed by NO capture by an iron porphyrin.45 
Considering that the intracellular chloride ion concentration is much lower than the 
extracellular concentration, Kim et al. proposed that the labile halide would be lost upon 
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entering the cell, yielding the active species [Fe(TMEDA)(NO)2]
+.45 Indeed, the 
activation of cisplatin is known to occur in this same manner, namely loss of Cl- upon 
entering the cell.46 Gene expression levels of heme oxygenase-1 increased significantly 
upon treatment of cells with [Fe(TMEDA)(NO)2I], while the inducible nitric oxide 
synthase expression was downregulated.45 Both these results were consistent with what 
is expected when cells are treated with NO.  
Understanding the chemistry of these DNICs and factors affecting their NO 
release is essential towards developing such complexes into NO-releasing 
pharmaceuticals. The most promising NO release agent in therapeutic development is 
the water soluble bis-glutathione DNIC reported by Vanin et al. Under the name 
Oxacom®, this NO-releasing drug is currently in phase II clinical trials.47,48 It has shown 
a host of biological activities including prolonged hypotension, attenuated platelet and 
erythrocyte aggregation, promotion of skin wound healing and effects on penile 
erection.48 In addition, Shamova et al. demonstrated that this glutathione containing 
DNIC blocks early stage cell aggregation in HeLa cells.49 
RSNOs and the Interplay of Cu and Fe in NO Release 
Unlike the rather unexplored area of NO release/transfer from DNICs, this 
process has been well studied in RSNOs, the other biological carrier of NO. The RSNOs 
are readily made from the electrophilic nitrosation of thiol groups on biomolecules 
ranging from sugars to amino acids or simple peptides. Within the plasma, the low 
molecular weight forms, for example S-nitrosoglutathione, are present in submicromolar 
concentrations.50 As a reservoir of NO, RSNOs participate in the post-translational 
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modification of proteins via S-nitrosation of cysteine residues, and are reported to 
protect against myocardium, lung and airway injuries.9  
Early kinetic studies of the rate of decomposition of RSNOs yielded conflicting 
and inconsistent results. Rate expressions of zero-, half-, first-, and intermediate-order 
were reported for aqueous solutions.51 These puzzling results were finally deconvoluted 
with the suggestion that trace metal ions were present in the media solutions used in 
these studies and could be promoting the RSNO decomposition. Indeed, addition of the 
metal chelator, EDTA, stopped the decomposition reaction, leading to the major finding 
that trace metal ions present in the media were responsible for the decomposition of 
RSNOs.52 Further studies in which Williams et al. added a slight excess of metal ions 
(over the amount of EDTA added) revealed that Cu2+, even at concentrations as low as 
10-6 mol dm-3 promoted the release of NO from the RSNOs.53 Ferrous ions also 
facilitated the reaction, albeit to a much lesser extent, while Mg2+, Zn2+, Ca2+, Ni2+, Co2+, 
Mn2+, Cr3+ or Fe3+ had no measurable effect.53  
Although copper was clearly the main catalyst for this decomposition reaction, in 
subsequent kinetic studies some findings, i.e. zero-order kinetics under some 
circumstances and an induction effect in many experiments, pointed to Cu+ rather than 
Cu2+ serving as the true promoter. Indeed, addition of neocuproine, known for its high 
affinity for and selective binding to Cu+, virtually stopped the decomposition reaction.54 
Subsequent studies by Williams, Payne, and Warren have further supported the fact that 
copper effectively catalyzes the decomposition of RSNOs, thereby releasing NO.55 
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Two catalytic pathways are suggested for the RSNO decomposition reaction, 
both of which are shown in Figure I-5, as adapted from an excellent review by 
Szaciłowski and Stasicka.56 Path (a) is proposed by Williams et al. in which Cu2+ is first 
reduced to the active Cu+ before reacting with the RSNO, thus producing NO gas and 
half an equivalent of RSSR.55  
 
 
 
 
 
 
 
 
In pathway (b), as proposed by Szaciłowski and Stasicka, the RSNO binds to the 
Cu2+ forming a Cu+-RSNO adduct through an intramolecular electron transfer.56 This 
adduct then decomposes to the radical RS·, NO+, and the catalytically active Cu+ species 
can then react with a second RSNO and produce NO.  
Figure I-5. The catalytic cycle involving Cu+ for the decomposition of RSNOs in 
vivo. Pathway (a) is proposed by Williams et al. and pathway (b) by Szaciłowski 
and Stasicka. Figure adapted from a similar figure from Szacilowski, K.; Stasicka, 
Z. Prog. React. Kinet. 2000, 26, 1-58.56,58 
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The binding modes of the RSNO to a metal center can be envisioned in four 
different ways, as proposed by Richter-Addo (Figure I-6).57 Experimentally, only S- and 
N-bonded coordination modes have been observed.56  
 
 
 
 
 
 
 
 
Electron rich metal ions, such as CuI would be expected to coordinate through the 
sulfur, which allows the occupied metal orbitals to engage in back donation. The S→M 
 bonding coupled with  back donation weakens the S-N bond. For those metal ions 
with unoccupied d-orbitals, bonding through the nitrogen would be preferred. However, 
Warren et al. recently reported RSNO binding to a CuI center, with bonding through the 
nitrogen.58  
Figure I-6. Four different binding modes are possible for the RSNO to a metal 
center. Working clockwise starting from the top right, there can be binding through 
the oxygen, through the nitrogen, through both the oxygen and the nitrogen, or 
through the sulfur. Adapted from a similar figure by Szaciłowski and Stasicka.56 
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In 2001, Vanin et al. questioned the conclusion that Cu+ was the primary catalyst 
for NO release from RSNOs by reporting that nitric oxide initiates the binding of 
neocuproine to FeII.59 This study merits consideration since Williams et al. used the 
selectivity of neocuproine for Cu+ as part of the evidence that Cu+ (rather than iron) was 
the primary catalyst.54  
In a subsequent study, Vanin et al. showed that addition of either Fe2+ or Fe3+ 
ions accelerated the degradation of RSNO (where R = cysteine) concomitant with the 
appearance of a DNIC, where the RSNO was the source of the NO in the DNIC.18 The 
DNICs were identified by the appearance of the prototypical EPR signals centered near g 
= 2.03, and assigned to either cysteine-containing (in the case where L-cysteine was also 
added) or to phosphate-containing DNICs (when in phosphate buffer).18  
 
 
 
 
 
 
 
 
Figure I-7. Proposed mode of interaction between iron and RSNOs, which results 
in the formation of a DNIC as opposed to releasing free NO, as is seen in the 
copper catalyzed system. 
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As shown in Figure I-7, these DNICs are thought to form when each iron ion 
binds two RSNOs through the nitrogen of the NO, providing for the mutual oxidation-
reduction of the RSNO molecules.18 Disulfide is then eliminated and the remaining NO 
and NO+ maintain their connection to the iron center thereby forming a DNIC.  
Although Vanin’s main claim is that iron rather than copper is the primary 
catalyst for RSNO decomposition, the studies by Williams and others discussed above 
are both thorough and extensive and provide compelling evidence for a seminal role of 
copper. The significance of Vanin’s work is not that iron instead of copper catalyzes 
RSNO decomposition, but rather that the role played by iron is intertwined with the 
formation of DNICs. Early discoveries by Williams support Vanin’s findings that 
ferrous ions do indeed catalyze RSNO decomposition, albeit not as effectively as do 
copper ions.52,55 What Vanin has highlighted, perhaps unrecognized, is a fascinating 
correlation between copper and the DNIU.  
Correlation Between Cu and DNIU 
The correlation between copper and the DNIU is not confined to the story 
regarding the decomposition of RSNOs. In fact, examples abound in both biological and 
chemical studies. Glutathione S-transferase (GST) is known to strongly bind copper.60-63 
Interestingly, the very first crystal structure of a protein-bound DNIC featured the GST 
protein.64 The electronic similarity of copper and the Fe(NO)2 unit is demonstrated in 
thiolate/disulfide interconversion reactions which involve the redox couples, 
{Fe(NO)2}
9/10 and CuII/CuI.65-68 Furthermore, Cu and Fe(NO)2 in their two redox levels 
can form structurally analogous complexes as showcased by tetramolecular and cluster 
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compounds wherein the Cu and Fe(NO)2 units occupy analogous sites.
15,69-71 This section 
will explore this correlation in depth. 
Glutathione S-Transferase (GST) 
Maintaining the redox balance of the cell is essential for survival. The balance is 
achieved by a tripeptide consisting of a glutamate, cysteine and glycine called 
glutathione (GSH), which exists at millimolar concentration in the cell.72 Glutathione 
serves as substrate for glutathione-S transferase (GST), in which capacity it facilitates 
the removal of species known to form reactive oxygen species (ROS) such as free 
radicals, peroxides, lipid peroxides and metal ions.73   
Glutathione-S transferases (GSTs) represent a family of enzymes, both cytosolic 
and membrane-bound, that serve as part of the cell detoxification mechanism by binding 
toxins and functioning as transport proteins.73,74 These enzymes, found predominately in 
the liver, protect the cell from harmful toxins such as carcinogenic metabolites and metal 
ions, by catalyzing the nucleophilic attack of glutathione (GSH) on electrophilic 
substrates.73 Foreign elements such as arsenic and lead are well known to be highly toxic 
to living organisms, but even those metals that are essential for life, such as iron and 
copper, must be tightly regulated.63 Unregulated metals in the cytosol damage cells by 
participating in Fenton chemistry which forms reactive oxygen species (ROS). Metals 
are also linked to improper protein folding and induce protein aggregation, as seen in 
Alzheimer’s and Parkinson’s disease.75 Hence, it is proposed that one of the roles played 
by GST is to bind and remove metal ions from the cell, as discussed in the following 
paragraphs.  
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Although not extensively explored, it is well established that GST binds metal 
ions.60-63  Early work linked the inhibition of tumor specific human GST activity to GST 
binding of mercury, cadmium and copper (II).76 A Caenorhabditis elegans GST 
homologue, GST-1, inhibited Mn-induced dopamine neurodegeneration, providing 
strong proof of GST interaction with Mn, albeit not direct evidence of binding.77  
In 1997, Neuefeind et al. solved an X-ray structure of apo-GST from maize, 
providing structural proof of metal binding. The structure contained several Cd2+ ions 
bound to the protein surface, and one Cd2+ bound to the GSH-binding site where N59 
and Q72 from one monomer and D106 from the partner chain formed the coordination 
sphere (Figure I-8).62,78 The CdSO4 from the crystallization buffer was the source of Cd 
in this study.  
When crystallized in the presence of zinc, three different crystal types were 
identified in three different crystal systems. One was a homo-dimeric GST with Asp26 
and His79 of one monomer and His46 from a neighboring molecule forming the 
coordination sphere of the zinc ion. In the second crystal type, the zinc ion is coordinated 
by Asp26, His79 and a water molecule in the place of the His46. When Asp26 is 
mutated with His, the zinc adopts the more typical biological binding environment 
comprised of four histidines that derive from two different dimers. Hence, the zinc 
connects two different GST dimers.  
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Each of these studies employed apo-GST and thus do not present a realistic 
representation of what the binding modes would be in the cellular environment, 
primarily because the actual substrate, GSH, was not present. Considering that the 
function of GST is to catalyze the binding of GSH to metal ions (or other xenobiotic 
substrates), the question remains whether a structure obtained in the presence of both 
GSH and a metal ion would have the GSH bound. It is possible, though, that in vivo the 
GSH does not remain bound to the metal (or other xenobiotic substrates) and merely acts 
Figure I-8. Overlay of the X-ray crystal structure of the cadmium binding site of L. 
vannamei GST with the molecular model of GST with the product GS-DNB. Reprinted 
with permission from “Inhibition by Cu2+ and Cd2+ of a mu‐class glutathione S‐transferase 
from shrimp Litopenaeus vannamei” by Salazar-Medina, A. J.; Garcia-Rico, L.; Garcia-
Orozco, K. D.; Valenzuela-Soto, E.; Contreras-Vergara, C. A.; Arreola R.; Arvizu-Flores, 
A.; Sotelo-Mundo, R. R.. J. Biochem. Molec. Tox., 2010, 24, 218-222, Copyright 2010 by 
John Wiley & Sons, Inc.62 
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to facilitate the binding to GST, which in turn delivers the toxic substance to the 
membrane-bound multidrug resistant protein-1 (MRP-1) for removal from the cell.  
The first realistic view of GST binding a metal ion in the presence of the GSH  
substrate was reported by Lo Bello et al. in 2005.64 An exogenously prepared bis-
glutathione DNIC, [(GS)2Fe(NO)2]
-, i.e. the oxidized, {Fe(NO)2}
9 form, was introduced 
to the GST, resulting in replacement of one of the GS ligands with the tyrosine of the 
GST active site (Figure I-9).64 Not only does this work model how the GST functions in 
vivo, but it also constitutes the first, and only, example of a protein-bound DNIC.  
 
 
 
 
 
 
Figure I-9. Exogenously prepared DNIC, [(GS)2Fe(NO)2]
- was introduced to GST, 
resulting in the loss of one of the GS- ligands as GSH and incorporation of the 
Fe(NO)2 unit into the GST active site via binding through the active site tyrosine 
residue.64 
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This study also provides yet another example of the similarities between the 
DNIU and copper, in this case {Fe(NO)2}
9 and Cu2+. It should be noted that the GST-
DNIC experiences a loss of GST activity, confirming that the DNIC tightly binds the 
active site of GST.64 
In studies assessing GST binding affinity for various metal ions, most find that 
Cu2+ binds GST with higher affinity than any other metal ion. Michibata et al. 
investigated the metal-binding affinity of GST from the vanadium-rich ascidian Ascidia 
sydneiensis samea.60 Immobilized metal ion affinity chromatography revealed the 
binding affinity of this particular GST was Cu(II) >V(IV) > Fe(III) with Co(II), Ni(II), 
and Zn(II) showing low binding affinities.60 However, GST activity was only inhibited 
by Cu(II). The same analysis performed on GST from an entirely different species also 
revealed that only Cu(II) inhibited GST activity.60  
In 2016, Ahmed et al. reported the effects of a range of metal ions (NaCl, KCl, 
FeCl2, LaCl2, MnCl2, CaCl2, MgCl2, NiCl2, ZnCl2, CdCl2, CoCl2, CuCl2, FeCl3, and 
AlCl3) on camel liver GST.
63 Of all the metals tested, CuII displayed the greatest 
inhibition of enzyme activity, readily attributed to the strong binding affinity of CuII for 
the thiol groups on GST. The high affinity of CuII for GST has also been shown in 
studies using GST from rat liver cells.61 Nevertheless, no structural evidence for the 
binding of Cu to GST has been reported to date.  
In summary, although the GST can bind many different metal ions, the highest 
affinity binding is for CuII. Additionally, when the Fe(NO)2 unit is introduced to GST, as 
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opposed to just iron ions, the binding affinity is also high. From this, it can be concluded 
that there is indeed a strong case for the similarity between copper and Fe(NO)2. 
Dithiolate Compounds 
An important artifact in the studies involving GST with copper and DNICs is the 
affinity of both the Cu ions and the Fe(NO)2 for sulfur donors. Some prominent 
endogenous thiol environments in which iron exists include iron sulfur clusters and the 
Cys-Gly-Cys binding motif of nitrile hydratase. Nitrous oxide reductase and cytochrome 
c oxidase both house copper in a CuA binding site that utilizes methionine and cysteine. 
Additionally, both the Fe(NO)2 and Cu have a high affinity for glutathione.  
Structural Analogy Between Cu and Fe(NO)2 
Nitrogen donor environments are also prevalent for both of these moieties as 
exhibited in the active sites of catechol oxidase and tyrosinase that contain copper 
coordinated by three histidine residues or the bis-histidine DNIC that has been 
spectroscopically observed. Accordingly, chemists have developed a vast library of both 
DNICs and Cu complexes with N- and S-donor ligands, many of which have already 
been mentioned. Amongst them, our group and others have extensively explored the 
N2S2 ligands, where N2S2 is predominately bis-mercapto-diazacycles, and the reactivity 
and properties of their metalated forms.  
The following paragraphs highlight structural similarities between the 
{Fe(NO)2}
10 and CuI incorporated into adamantane-like structures with N2S2, as well as 
tetramolecular structures that incorporate {Fe(NO)2}
9 and CuII in a N-donor 
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environment. Furthermore, we consider the electronic similarities of the {Fe(NO)2}
9/10 
and CuII/CuI redox couples with regards to thiolate/disulfide interconversion. 
Due to the high affinity of N2S2 ligands for divalent metals, a rather extensive 
library of complexes has been synthesized and characterized.79 Moreover, the thiolate 
sulfurs show reactivity towards electrophiles such as metals and oxygen. The reactivity 
of these sulfurs towards both copper and Fe(NO)2 provides an excellent example of 
structural similarity between complexes formed from these two units.  
Reaction of Cu(N2S2) (N2S2 = bis(N,N’-2-mercapto-2-methylpropyl)-1,5-
diazocyclooctane) with CuICl forms a cluster complex in which two Cu(N2S2) 
metalloligands are bridged by CuICl via attachment of the Cu to the thiolate sulfurs. This 
bridging core region was noted to bear a remarkable resemblance to adamantane as 
displayed in Figure I-10.69 
 
 
 
 
 
 
 
 
Figure I-10. The structure of adamantane (left) and the adamantane core of the 
Cu(N2S2) cluster (right).  
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The major product isolated in this reaction was the cluster with a complete adamantane 
core, while the minor product was also analyzed and found to contain an “incomplete 
adamantane core”. This incomplete core contains only three (instead of four) bridging 
CuICls.  
As will be discussed in detail in Chapter III, a similar cluster complex with an 
adamantane core was isolated when [Ni(N2S2)Fe(NO)2(CO)] (where N2S2 = N,N′-bis (2-
mercaptoethyl)- 1,4-diazacycloheptane) was reacted with Fe(CO)2(NO)2.
70 The resulting 
complex contained two Ni(N2S2) units bridged by three Fe(NO)2 units, which formed an 
incomplete adamantane core analogous to that seen in the copper case discussed above.  
 
 
 
  
 
 
 
 
 
Figure I-11 shows a chemdraw sketches of both the Cu cluster and the Fe(NO)2 
cluster. The two incomplete adamantane cores overlay nearly perfectly when the 
Figure I-11. Chemdraw depictions of the analogous incomplete 
adamantane structures in which either CuICl (left) or Fe(NO)2 (right) 
occupies equivalent sites within the core. 
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structures are overlaid, providing an excellent example of two structurally analogous 
compounds that can house either CuI or {Fe(NO)2}
10 in equivalent positions. 
 
 
 
 
 
 
 
 
Structurally analogous complexes containing the d9 CuII and {Fe(NO)2}
9 have 
also been isolated. In this case, nitrogen donor ligands in the form of imidazoles form 
tetramolecular squares in which four imidazole ligands bridge either CuIIL, where L = 
1,4,7-triazacyclononane)71 or {Fe(NO)2}
9,22 which occupy the corners of the square 
(Figure I-12). Again, this example provides yet another insight into the similarity 
between copper and Fe(NO)2.  
Figure I-12. Chemdraw depiction of tetramolecular squares with imidazole linkers in 
which either {Fe(NO)2}
9 or CuIIL (L = 1,4,7-triazacyclononane) occupy the corners. 
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Similarity Between {Fe(NO)2}9/10 and CuII/CuI Redox Couples with Regards to 
Thiolate/Disulfide Interconversion 
The conversion interconversion between thiolates and disulfide is well known in 
biology, namely as was discussed with regards to the redox buffering activity of GSH in 
the section covering GSH/GST.  We also note that conversion of thiolates to disulfide 
also occurs in RSNO decomposition reactions. Other systems, such as the metalloprotein 
that delivers Cu superoxide dismutase 1 (SOD1), forms disulfide bonds from cysteinyl 
thiolates as part of the Cu insertion process.80 In this reaction, the Cu serves as the 
oxidant for disulfide formation. 
Following the idea of copper involvement in thiolate/disulfide interconversion, 
Henkel et al. reported a chloride-induced conversion of a copper(I) disulfide cation 
[CuI2{(NGuaS-)2}2]
2+ (NGuaS = o-SC6 H4 NC(NMe2)2) to the electrically neutral 
copper(II) thiolate species [CuII2-(NGuaS)2Cl2].
68 Our group noticed a similar 
thiolate/disulfide interconversion with a DNIC (instead of the Cu seen in the previous 
example).65 Upon exposure to CO gas, the oxidized {Fe(NO)2}
9 DNIC 
[(sIMes)(SPh)Fe(NO)2], (where sIMes = 1,3- bis(2,4,6- trimethylphenyl)- imidazole and 
SPh = thiophenol) converts to the {Fe(NO)2}
10 species [(sIMes)(CO)Fe(NO)2] 
concomitant with release of disulfide.  
Summary and Overview 
As discussed in this chapter, the vital importance of nitric oxide to living 
organisms has propelled a large number of studies regarding NO storage and transport 
agents, specifically the DNICs. Chemical and biochemical studies have elucidated the 
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basic chemistry of these complexes and have built an extensive library of biomimetic 
DNICs that provide scaffolds for further exploring the DNIC field, although the 
mechanism of NO release and development of viable pharmaceutical candidates is still 
lacking. The work reported in this dissertation addresses both of these lacking areas.  
In Chapter III, the reactivity of DNICs with copper is explored. These reactions 
have implications in DNIC reactivity with components of the cellular environment, and 
further build the case for the correlation between copper and DNICs that was discussed 
in detail in this chapter. This study also exemplifies copper-initiated nitric oxide release, 
suggesting copper might serve as an endogenous trigger for NO release from DNICs. 
Chapter IV examines the reactivity of RSNOs with DNICs, addressing the 
hypothesis that DNICs may play a role in NO release from RSNOs. While NO release is 
observed, this study also focuses on the formation of a unique cluster and its 
implications in iron-sulfur cluster repair. 
New DNICs containing thioglucose ligands are presented in Chapter V and their 
application as biocompatible NO-releasing molecules is described. The use of the 
glucose ligands provides the potential for low cytotoxicity, water solubility and 
increased cell permeability over traditional inorganic ligand sets. 
Finally, Chapter VI presents several structural examples of the Fe(NO)2 unit 
bound to both metallodithiolate and phosphene ligands and provides insights into the 
various binding modes of each ligand.   
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CHAPTER II 
EXPERIMENTAL SECTION FOR CHAPTERS III-V 
 
Abbreviations 
DNIU :  Dinitrosyl iron unit 
DNIC :  Dinitrosyl iron complex 
RRE :  Roussin’s red ester 
Neo :  2,9-dimethyl-1,10-phenanthroline (neocuproine) 
NHC :  N-heterocyclic carbene 
SGlu :  1-thio--D-glucose tetracetate  
bme-dach :  bis(N,N’-2-mercapto-2-methylpropyl)-1,5-diazocycloheptane  
bme-daco :  bis(N,N’-2-mercapto-2-methylpropyl)-1,5-diazocyclooctane 
DCM :  Dichloromethane 
THF : Tetrahydrofuran 
General Methods and Materials 
All chemical reactions were carried out under air-free conditions using standard 
Schlenk techniques or in an argon-filled glovebox. Solvents were of reagent grade and 
were freshly purified by an MBraun manual solvent purification system packed with 
Alcoa F200 activated alumina desiccant. Tetrahydrofuran was further purified by 
distillation under N2 from sodium-benzophenone. Many of the X-ray quality crystals 
obtained are described to have been grown from slow diffusion of a hexanes/ether 
mixture into a concentrated DCM or THF solution of the product. These crystallizations 
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were set up by first adding a small amount of the concentrated product solution to a test 
tube. A layer of hexanes (ca. twice as much as the volume of the product solution) was 
added next. Enough ether was then added as a top layer to fill the test tube, after which 
time the layered mixture was carefully placed in the freezer.  
Physical Measurements 
Infrared spectra were recorded on a Bruker Tensor 27 FTIR spectrometer using 
CaF2 solution cells with a path length of 0.1 mm. Mass spectrometry (ESI-MS) was 
performed by the Laboratory for Biological Mass Spectrometry at Texas A&M 
University. Nanoelectrospray ionization in positive mode was performed on solution 
samples using an Applied Biosystems QSTAR Pulsar (Concord, ON, Canada) equipped 
with a nanoelectrospray ion source. Solution was flowed at 700 nL/min through a 50 μm 
ID fused-silica capillary that was tapered at the tip. Electrospray needle voltage was held 
at 1900 V. Elemental analyses of crystalline samples were determined by Atlantic 
Microlab, Inc., Norcross, GA. Electron Paramagnetic Resonance (EPR) spectra were 
recorded in frozen THF, DCM or DMSO using a Bruker ESP 300 equipped with an 
Oxford ER910 cryostat operating at 10 K. The SpinCount software was obtained from 
Prof. Mike Hendrich at Carnegie Mellon University and was used to simulate spectral 
parameters. UV-vis absorption spectra were collected on a Shimadzu UV-2450. Cyclic 
voltammograms were recorded on a BAS-100A electrochemical analyzer. All CV 
experiments were performed at room temperature under an Ar blanket in CH3CN or 
DCM solution containing 0.1 M [t-Bu4N][PF6] as the electrolyte, with a 3.0 mm glassy 
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carbon working electrode, a Ag/AgNO3 reference electrode, and a Pt coil counter 
electrode. All values have been internally referenced to Cp2Fe/Cp2Fe
+.  
X-ray Crystallography 
X-ray diffraction (XRD) studies were carried out using a Bruker APEX2 using 
MoK radiation (0.7107 Å). Selected crystals were coated in paraffin oil, mounted on a 
nylon loop, and placed under streaming N2 (110/150 K). The space groups were 
determined by systematic absences and intensity statistics, and structures were solved by 
direct methods and refined by full-matrix least-squares on F2. Anisotropic displacement 
parameters were employed for all non-hydrogen atoms; H atoms were placed at 
idealized positions and refined with fixed isotropic displacement parameters. The 
following programs were used: cell refinement, data collection, data reduction, 
APEX281; absorption correction, SADABS82; structure solutions, SHELXS-9783; and 
structure refinement, SHELXL-97.83 The final data presentation and structure plots were 
generated in Mercury Version 3.8.84 CIF files were prepared for publication using 
WinGX85 and its included programs.  
Experimental Details for Chapter III 
Materials  
Reagents, including nitrosonium tetrafluoroborate, 2,9-Dimethyl-1,10-
phenanthroline, copper(I) chloride, copper(I) bromide, Tetrakis(acetonitrile)copper(I) 
hexafluorophosphate, copper(II) chloride, and copper(II) bromide were purchased from 
either Sigma-Aldrich Chemical Co. or VWR Chemical Co. and were used as received. 
Standard Schlenk-line techniques (N2 atmosphere) and an Ar-filled glovebox were used 
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to maintain anaerobic conditions during preparation, isolation, and product storage. 
Fe(CO)2(NO)2
86 and [Na-18-crown- 6-ether][Fe(CO)3(NO)]
87 were prepared according 
to published procedures. 
Synthesis of Complex 1  
Sodium tetrafluoroborate (0.2 mmol, 0.023 g) and [Na-18-crown- 6-
ether][Fe(CO)3(NO)] (0.2 mmol, 0.091 g) were added to a Schlenk flask, dissolved in 
THF and stirred for 15 min. The resulting Fe(CO)2(NO)2 was vacuum transferred to a 
second Schlenk flask. Neocuproine (0.042 g, 0.2 mmol) was loaded into a round bottom 
flask, dissolved in THF, and then added to the freshly prepared Fe(CO)2(NO)2. During 
the 1 h stir, the color changed from orange red to dark brown, indicating the formation of 
the product [(neo)Fe(NO)2] (1). This dark brown product solution was filtered through 
Celite and the solvent removed in vacuo. After drying, the dark brown solid was washed 
with hexanes (3x10 mL) to yield spectroscopically pure 1 as a dark brown powder 
(0.034 g, 52 %). X-ray quality crystals of 1 were obtained by slow diffusion of a 
hexanes/ether mixture into a DCM solution of 1 at -35 °C. IR (cm-1): 
Cyclic Voltammetry: E1/2: -0.36 V. UV-Vis: 802, 662, 373, 360, 
328, 314, 273. Elem. anal. found (calc’d for C14H12FeN4O2) %: C, 46.03 (47.23); H, 4.66 
(5.01), N, 11.18 (11.60). 
Chemical Oxidation of 1 to Form 1+  
A round bottom flask containing a THF solution of ferrocenium 
hexafluorophosphate was cooled to -78oC using a dry ice/acetone bath. This cooled 
solution was then added slowly to a THF solution of 1, also at -78oC. The reaction 
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mixture was stirred at -78oC for 1 h. The resulting light brown solution was stable upon 
warming to room temperature. IR spectroscopy confirmed complete conversion to 1+. 
Following solvent removal, the light brown powder was washed with hexanes (3x10 
mL) and dried. Due to thermal instability, an accurate yield was not determined. IR 
(THF, cm-1): , 1769). +ESI-MS for C28H24FeN6O2 (MW=532 g/mol): m/z = 
533.3 [M + H]+. Instability prevented collection of reliable elemental analysis data. 
Reactivity Studies with CuI  
Three reactions were conducted to study the potential binding of CuI or the 
DNIU to neocuprione. All reactions with CuI were carried out at 22˚C. In the first 
reaction, a 1:1 mixture of CuICl and 1 was dissolved in THF and left to stir overnight. A 
color change from brown red to orange-red occurred, and the resulting solution showed 
complete disappearance of the NO bands of 1 and no new bands appeared. IR (THF, cm-
1):  none. +ESI-MS for CuC28H24N4 (MW=479 g/mol): m/z = 479 [M]+, and UV-
Vis (, nm): 454, 336, 324, 291, 274, 226 (indicates the formation of [Cu(neo)2]Cl, a 
previously synthesized compound).88 
In the second reaction, [Cu(CH3CN)4]PF6 was dissolved in THF and added to a 
round bottom flask containing a THF solution of 1 (1:1). The reaction was allowed to 
stir overnight. A change of color to orange-red was again observed. The resulting 
solution was then characterized by IR, mass spectrometry and UV-Vis and all revealed 
the same results as the first reaction, indicating that the main product for both reactions 
is [Cu(neo)2]
+.   
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The same reaction was again carried out but with CuBr. Results again showed 
disappearance of the IR NO bands and a mass spectrum and UV-vis spectrum that 
showed the only major product to be [Cu(neo)2]
+.    
Finally, in a round bottom flask, THF solutions of CuICl (0.1 mmol, 0.010 g) and 
Fe(CO)2(NO)2 (0.1 mmol, 0.046 g) were mixed, and monitored for any reactivity. No 
change in color was observed, even after hours of stirring. IR spectroscopy confirmed 
the presence of unreacted Fe(CO)2(NO)2. A THF solution of neocuprione (0.1 mmol, 
0.021 g) was then added to the round bottom flask containing the two compounds. After 
a 3 h stir, a color change to orange red was observed. The resulting major product was 
identified as [Cu(neo)2]
+. IR (THF, cm-1):  none. +ESI-MS for CuC28H24N4 
(MW=479 g/mol) : m/z = 479 [M]+, and UV-Vis (, nm): 454, 336, 324, 291, 274, 226 
Reactivity Study with CuII (1:1 Stoichiometry)  
To a Schlenk flask containing a brown CH3CN solution of 1 (0.02 mmol, 0.065 
g) was slowly added a bright green CH3CN solution of CuBr2 (0.02 mmol, 0.045 g). 
Upon addition, there was an immediate color change to a dark red-brown. IR 
spectroscopy showed the disappearance of the NO bands of 1 and formation of two new 
bands at 1777 and 1716 cm-1. The reaction was monitored by both IR spectroscopy and 
UV-vis spectroscopy for 5 h, in which time no additional changes occurred. The product 
mixture was dried in vacuo, dissolved in a minimal amount of DCM and precipitated 
with hexanes. The brown solid mixture was then washed with hexanes (3 x 10 mL), and 
filtered. X-ray quality crystals of one of the products, (neo)CuBr2 (neo = 2,9-dimethyl-
1,10-phenanthroline), complex 2, were obtained by slow diffusion of a hexanes/ether 
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mixture into a DCM solution at -35 °C. Spectroscopic analysis of the dark red-brown 
product solution indicated the formation of two copper species, [Cu(neo)2]
+ and 2 in 
addition to the iron nitrosyl products (one confirmed to be Fe(NO)2Br2
-). IR: 
1777, 1716 cm-1. +ESI-MS for CuC28H24N4 (MW = 479 g/mol): m/z = 479 [M]+, 
and for CuC14H12N2Br2 (MW = 432 g/mol): m/z = 352 [M-Br]
+. UV-Vis (, nm): 277, 
448, 567, 857.  
The reactions with CuX2 (X = Cl, Br) as detailed above, were also each carried 
out in a vial, which was placed in a larger sealed vial containing the NO trapping agent 
[(bme-daco)Fe]2 (bme-daco = (N,N′-bis(2- mercaptoethyl)-1,4-diazacycloheptane)) 
dissolved in DCM. Nitric oxide evolution was confirmed by the formation of [(bme-
daco)Fe(NO)],  = 1648 cm-1. 
Reactivity Study with CuII (2:1 Stoichiometry)  
Using the same synthetic methods described above, THF solutions of 1 (0.04 
mmol, 0.13 g) and CuBr2 (0.02 mmol, 0.090 g) were mixed in a 2:1 stoichiometric ratio. 
The reaction occurred more slowly than with the 1:1 stoichiometry, with starting 
material remaining after 10 min of stirring. After stirring overnight, the IR spectrum of 
the dark red-brown solution showed only product bands (1777, 1716 cm-1). Mass 
spectrometry and UV-vis spectroscopy showed that the only copper product was 
[Cu(neo)2]
+. IR: 1777, 1716 cm-1. +ESI-MS for CuC28H24N4 (MW = 479 g/mol): 
m/z = 479 [M]+. UV-Vis (, nm): 454, 336, 324, 291, 274, 226. 
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Synthesis of Complex 2 (and 3)  
In a Schlenk flask, DCM (30 mL) was added to CuBr2 (0.10 mmol, 0.022 g) and 
the solution sonicated for 30 min. Neocuprione (0.10 mmol, 0.020 g) was added to the 
CuBr2 slurry and left to stir for 2 h. A change in color from the black slurry to yellow to 
brownish red was observed and the crude product was dried, washed with hexanes (3x10 
mL), dissolved in DCM and then filtered. The solution was dried under a flow of N2 gas 
to yield (neo)CuBr2 (2) as a dark powder. X-ray quality crystals were obtained by slow 
diffusion of a hexanes/ether mixture into a DCM solution. Cyclic voltammetry: E1/2: -
0.17 V. UV-Vis (λ, nm): 802, 570, 465, 375, 350, 300. Elem. anal. found (calc’d for 
C14H12N2CuBr2
.C2H6O) %: C, 40.23 (40.27); H, 3.80 (3.60), N, 5.86 (5.90).   
Synthesis of Complex 4  
Complex 4 was prepared in a similar manner to 2 but using CuCl2.H2O as the 
copper source. In this case, the product solution was a green brown color. X-ray quality 
green crystals were obtained by slow diffusion of a hexanes/ether mixture into a DCM 
solution. Cyclic Voltammetry: E1/2: -0.36 V. UV-Vis: 802, 662, 373, 360, 328, 314, 273. 
Elem. anal. found (calc’d for C28H24N4CuCl2H2O. CH2Cl2) %: C, 54.78 (55.32); H, 4.12 
(4.24), N, 8.81 (9.10). 
Synthesis of Complex 5  
[Na-18-crown- 6-ether][Fe(CO)3(NO)] (0.50 mmol, 0.240 g), NOBF4 (1.0 mmol, 
0.116 g) and NaBr (1.0 mmol, 0.103 g) were loaded into a Schlenk flask under an argon 
atmosphere, dissolved in approximately 30 mL of THF, and stirred for 2 h. A change of 
color from orange to brown was observed, and the crude product was dried, washed with 
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hexanes (3x10 mL), and filtered through Celite to yield spectroscopically pure 5 (yield). 
X-ray quality crystals of 5 were obtained by slow diffusion of a hexanes mixture into a 
THF solution. IR (cm-1):  (NO): (1783, 1715). UV-Vis (λ, nm): 701, 523, 463, 423. 
Synthesis of Complex 6 
[Na-18-crown- 6-ether][Fe(CO)3(NO)] (0.25 mmol, 0.120 g), NOBF4 (0.50 
mmol, 0.058 g) and CuBr (0.50 mmol, 0.082 g) were loaded into a Schlenk flask under 
an argon atmosphere, dissolved in approximately 30 mL of THF and stirred for 12 h. A 
change of color from orange to brown was observed and the crude product was dried, 
washed with hexanes (3x10 mL); the product was redissolved in a minimal amount of 
THF and filtered through Celite to yield spectroscopically pure 6. IR(cm-1): (NO): 
(1793, 1793). 
Synthesis of (-Br)2[Fe(NO)2]2 
In a Schlenk flask, Br2 (0.30 mmol, 7.7 L) was dissolved in THF, then added to 
freshly prepared Fe(CO)2(NO)2 and stirred for 90 min. A slight change of color from 
orange to dark brown was observed. The product solution was dried in vacuo, dissolved 
in hexanes, and then filtered through Celite. Attempts at crystallization via slow 
evaporation of the concentrated hexanes solution were unsuccessful.  IR(cm-1):  NO): 
(1816, 1712). 
Quantification of NO Release  
A small vial was charged with 1 (0.050 mmol, 0.016 g) and CuBr2 (0.050 mmol, 
0.011 g) and placed inside a larger vial containing [Co(bme-dach)]2 (0.05 mmol, 0.030 
g) and sealed under argon. The contents of each vial were dissolved in 5 mL of DCM 
40 
 
 
and stirred for 12 h. A color change was observed in the solution of the outer tube 
reaction and confirmed to be [Co(bme-dach)]NO by the appearance of a single NO band 
at 1601 cm-1. The intensity was compared to a known intensity-concentration plot for 
[Co(bme-dach)]NO. The product of the inner vial was characterized by IR, which 
showed two main stretches at IR(cm-1): NO): (1777, 1716). In a similar manner, the 
amount of NO released in the reactions with CuCl2 and CuX (X = PF6, Br, Cl) was also 
analyzed. The same molar scales and reaction times were also used. 
Experimental Details for Chapter IV 
Materials 
Reagents, including nitrosonium tetrafluoroborate and tritylthiol, were purchased 
from either Sigma-Aldrich Chemical Co. or VWR Chemical Co. and were used as 
received. Standard Schlenk-line techniques (N2 atmosphere) and an Ar-filled glovebox 
were used to maintain anaerobic conditions during preparation, isolation, and product 
storage. Fe(CO)2(NO)2 and [Na-18-crown-6-ether][Fe(CO)3(NO)] were prepared 
according to published procedures.86,87 The amylnitrite,89 used in the synthesis of 
tritylthiol, as well as the trityl-S-nitrosothiol,90 were prepared according to published 
procedures. 
Synthesis of Complex 1 from Ph3CSNO 
A Schlenk flask was loaded with sodium tetrafluoroborate (0.10 mmol, 0.012 g) 
and [Na-18-crown- 6-ether][Fe(CO)3(NO)] (0.10 mmol, 0.046 g), which were dissolved 
in THF and stirred for 15 min. The resulting orange-red Fe(CO)2(NO)2 was vacuum 
transferred to a second Schlenk flask immersed in liquid N2. Upon warming the 
41 
 
 
Fe(CO)2(NO)2 solution to room temperature, a green THF solution (~ 5 mL) of 
Ph3CSNO (0.10 mmol, 0.031 g) was added. IR spectroscopy revealed complete 
disappearance of the reactant IR bands concomitant with the appearance of two new 
bands (1787, 1752 cm-1) following a 1 h stir. A color change to dark brown also 
occurred during this time, signaling the formation of complex 1. The product solution 
was dried in vacuo, redissolved in hexane and filtered through Celite to yield 
spectroscopically pure complex 1. X-ray quality crystals were grown from the slow 
evaporation of a concentrated hexanes solution. IR (cm-1): NO): (1787, 1752).  
Synthesis of Complex 1 from Ph3CSH 
The reaction outlined above was again carried out but this time with 
Fe(CO)2(NO)2 (0.1 mmol, 0.017 g) and tritylthiol (Ph3CSH) (0.1 mmol, 0.028 g). The 
THF mixture was stirred for 1 h, after which time a color change to dark brown and a 
shift in the IR bands to 1787 and 1752 cm-1 indicated formation of complex 1. There was 
no nitric oxide release in this case. X-ray quality crystals were grown from the slow 
evaporation of a concentrated hexanes solution. IR (cm-1): NO): (1787, 1752). 
Synthesis of Complex 2 from Ph3CSNO 
A Schlenk flask was loaded with (neo)Fe(NO)2 (0.10 mmol, 0.032 g) and trityl-
S-nitrosothiol (0.10 mmol, 0.031 g). The mixture was dissolved in THF and stirred for 1 
h. The IR spectrum of the resulting product solution showed a shoulder at 1788 cm-1 and 
two major NO stretches at 1780 and 1747 cm-1. The reaction mixture was dried in vacuo, 
and hexanes were added. Part of the dark brown product dissolved in the hexanes, which 
was identified by IR spectroscopy to be complex 1. The hexane solution was removed, 
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leaving a dark brown hexane-insoluble solid. This solid was then washed with hexanes 
(3x10 mL), dissolved in DCM, and filtered through Celite to yield complex 2. X-ray 
quality crystals of 2 were grown by slow diffusion of a hexanes/ether mixture into a 
DCM solution. IR (cm-1): NO): (1780, 1747).  
NO Trapping Experiments  
A small vial was charged with a THF solution of freshly prepared Fe(CO)2(NO)2 
(0.050 mmol, 0.010 g) and placed in a larger vial containing [Fe(bme-dach)]2 (0.02 
mmol, 0.13 g). A THF solution of trityl-S-nitrosothiol (0.050 mmol, 0.015 g) was added 
to the inner vial and DCM was added to the [Fe(bme-dach)]2 in the outer tube. Over the 
course of an hour stir, the solution in the inner vial changed from brown-green to dark 
brown. The solution in the outer tube changed from brown to dark green, indicating the 
formation of [Fe(bme-dach)NO]; a single NO band at cm-1 in the IR spectrum 
confirmed the presence of [Fe(bme-dach)NO]The product of the inner vial was 
characterized by IR spectroscopy and confirmed to be complex 1.  
The exact experiment as above, using the same amounts and conditions, was 
carried out but with tritylthiol (0.050 mmol, 0.014 g) in the place of trityl-S-nitrosothiol. 
After an hour stir, the inner tube showed formation of complex 1, as confirmed by IR 
spectroscopy. However, there was no change in the color of the outer vial (it remained 
brown). Additionally, IR spectroscopy of the solution from the outer vial revealed no 
nitrosyl band formation.  
Again, the same experimental setup and amounts were used as outlined above, 
but with (neo)Fe(NO)2 as DNIC. A small vial was loaded with (neo)Fe(NO)2 (0.050 
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mmol, 0.016 g) and placed in a larger vial containing [Fe(bme-dach)]2 (0.02 mmol, 0.13 
g). Trityl-S-nitrosothiol (0.050 mmol, 0.015 g) was then dissolved in THF and added to 
the inner vial, while the [Fe(bme-dach)]2 in the outer tube was dissolved in DCM. 
Following an hour stir, a color change from brown-green to dark brown was observed in 
the inner vial, which was confirmed by IR spectroscopy to be a mixture of 1 and 2. A 
color change from brown to dark green, indicated the formation of [Fe(bme-dach)NO], 
which was confirmed by IR spectroscopy. 
Experimental Details for Chapter V 
Materials 
All reagents, including 1,3-bis(2,4,6-trimethylphenyl)imidazolium chloride 
(IMesH+Cl-), sodium tert-butoxide (NaOtBu), sodium methoxide (MeONa) 1-thio-β-D-
glucosetetraacetate, 1-thio-β-D-glucose sodium salt and CoTPP were purchased from 
Sigma-Aldrich Chemical Co. and were used as received. Air-free conditions were 
maintained during synthesis, isolation, and storage of products through the use of 
standard Schlenk-line techniques (N2 atmosphere) and an Ar-filled glove box. The NHC 
stabilized IMes-TNIC, [(IMes)Fe(NO)3]
+, [(bme-dach)Co]2, and complex 3 were 
synthesized according to literature procedures.70,91 Complex 4 was synthesized as 
described in Chapter III. Bovine coronary venular endothelial cells (CVECs) were kindly 
gifted by Professors Cynthia J. Meininger and Andreea Trache at Texas A&M Health 
Science Center.  CVECs were cultured in GIBCO® Dulbecco's Modified Eagle 
Medium: Nutrient Mixture F-12 (DMEM/F-12) (Invitrogen, Carlsbad, CA) mixed with 
10% fetal bovine serum (Sigma Aldrich, St. Louis, MS), 100 U/mL penicillin - 100 
44 
 
 
U/mL streptomycin - 0.25 mg/mL amphotericin B (Lonza, Walkersville, MD), and 20 
units/mL heparin (Midwest Vet Supply, Lakeville, MN).   
Synthesis of Complex 1 
A 0.10 mmol (0.054 g) portion of [(IMes)Fe(NO)3]
+ and 0.10 mmol (0.036 g) of 
1-thio-β-D-glucosetetraacetate were weighed and dissolved in 10 mL of THF in a 100 
mL Schlenk flask. A color change from green to brown resulted within time of mixing 
and the formation of complex 1 was confirmed by IR spectroscopy. The solution was 
filtered through Celite, and 1 (0.066 g, 83%) was isolated as a brown powder by 
recrystallization of THF solutions of 1 with cold hexanes or pentane. X-ray quality 
crystals of 1 were obtained from THF solutions layered by hexanes at -35 °C. IR (THF, 
cm-1) υ(Me-C(O)O): 1759 (s), 1749 (sh) cm-1 υ(NO): 1768 (sh), 1718 (s) cm-1.  
Elemental Anal. calculated for C35H43FeN4O11S (found) : C, 53.64 (53.21); H, 5.53 
(5.42); N, 7.15 (6.73). C35H43FeN4O11S (MW = 783 g/mol) 
+ESI-MS: m/z = 784 [M + 
H]+. Room temperature EPR measurements showed an isotropic signal at g = 2.03. Upon 
exposure to air for 3 h, 1 converted to an unidentified species that has the appearance of 
a mononitrosyl iron complex. IR (DMSO, cm-1) υ(NO): 1663. 
Deprotection of Complex 1 to Give Complex 1′ and the Direct Synthesis of 1′ 
In a 100 mL Schlenk flask, 0.040 g (0.05 mmol) of complex 1 was mixed with 
excess (0.40 mmol, 0.022 g) of MeONa and the solid mixture was dissolved in 20 mL of 
MeOH. The deprotection proceeded with changes in the IR pattern of complex 1, and 
was complete in ca. 2 h. Direct synthesis of complex 1′ was achieved by reacting 0.10 
mmol (0.054 g) of [(IMes)Fe(NO)3]+ and 0.10 mmol (0.022 g) of 1-thio-β-D-glucose 
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sodium salt in THF. The reaction was complete within time of mixing as confirmed by 
IR spectroscopy and a greenish brown product was obtained in powder form in good 
yield (crude yield > 75%). IR (THF, cm-1) υ (NO): 1768 and 1716 cm-1. 
C27H35FeN4O7S(MW = 615 g/mol) +ESI-MS: m/z = 638 [M + Na]+. 
Synthesis of Complex 2  
The Roussin’s Red Ester type dimeric complex 2,  (µ-(SR))2[Fe(NO)2]2, where R 
= acetylated thiosugar units, was synthesized by the room temperature reaction of 1 
mmol of 1-thio-β-D-glucosetetraacetate with 1 mmol of freshly prepared Fe(CO)2(NO)2 
(isolated by vacuum transfer to a flask immersed in  liquid N2) in ~ 30 mL THF solution. 
The reaction was complete in about 12 h as monitored by IR spectroscopy. A brown 
powdery product was obtained in good yield (0.36 g, 75.1%), by recrystallizing 
concentrated THF solutions (~ 5 mL) of 2 with cold hexanes (~20 mL). Room 
temperature EPR measurements showed no signal in DCM. However, a rhombic signal 
with gx=2.043, gy=2.030, gz=2.013 appeared in DMSO solution. IR (THF, cm-1) υ(NO): 
1787, 1750 cm-1 υ(Me-C(O)O): 1759, 1749 cm-1. Elemental Anal. calculated for 
C28H38Fe2N4O22S2●THF (found) : C, 37.30 (37.63); H, 4.50 (4.41); N, 5.44 (4.65).  
C28H38Fe2N4O22S2 (MW = 958 g/mol) +ESI-MS: m/z = 959 [M + H]+ , 980 [M + Na]+.  
NO Trapping Experiments 
Complex 1 was used in NO trapping experiments with Co(TPP). Into a 50 mL 
Schlenk flask, 0.060 mmol (0.050 g) of 1 was weighed out and dissolved in 10 mL of 
THF. This was transferred via cannula into a different flask containing 0.12 mmol (0.081 
g) of CoTPP in 10 mL THF. Loss of NO bands was seen over 48 hours in the IR monitor. 
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In order to isolate the (TPP)Co(NO), the solution was concentrated to ca. 5 mL, and 
MeOH was added. Careful decanting of the red supernatant showed a dark purple 
precipitate. The residue was dried in vacuo and re-dissolved in dichloromethane. The IR 
spectrum of this dichloromethane solution showed a strong absorption peak at 1683 cm-1 
for (TPP)Co(NO). +ESI-MS: m/z = 671 [(TPP)Co]+ . UV-Vis (DCM): 410 nm, 534 nm.  
Complex 1 (0.025 mmol, 0.019 g) and 2 (0.025 mmol, 0.023 g) were individually 
reacted with 0.10 mmol (0.056 g) of [(bme-dach)Co]2 in THF solutions separately. Loss 
of NO bands in the IR monitor was seen over ~24 h for 1 and over ~12 h for 2. The 
resulting solution was dried in vacuo and washed x2 with Et2O. The remaining solid was 
re-dissolved in dichloromethane, of which the IR showed a strong, broad band at 1601 
cm-1, indicating the formation of (bme-dach)Co(NO). When the reactions were carried 
out in DCM, loss of the NO bands was seen over ~48 h for 1 and ~24 h for 2.  +ESI-
MS:m/z = 308 [M + H]+ , 277 [M-NO].  
Quantification of NO Trapped by [(bme-dach)Co]2  
A series of DCM solutions of Co(bme-dach)NO were prepared with 
concentrations ranging from 3-14 mM. A calibration curve (below) was created using 
the intensities of the NO band at 1601 cm-1 and the concentrations. Complex 1 (0.008 g, 
0.008 mmol) and 2 (0.008 g, 0.01 mmol) were separately mixed with an excess of 
[Co(bme-dach)]2 and stirred in DCM for 24 h. The reaction mixture was then dried in 
vacuo and the solid residue dissolved in 5 mL DCM. IR of 1 revealed the formation of 
Co(bme-dach)NO (0.002 g, 0.005 mmol) ca. 0.5 moles Co(bme-dach)NO per mole 1, 
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while 2 showed the formation of Co(bme-dach)NO (0.007 g, 0.02 mmol) in a ratio of 2.7 
moles Co(bme-dach)NO per mole 2. 
Griess Assay Analysis  
The release of NO from the compounds under physiological conditions was 
quantitatively measured by the Griess assay (Invitrogen) following the manufacturer’s 
protocol. For each measurement, compounds 1-4 were mixed with the media, which was 
taken from 96-wells with and without cells, and incubated at 37 ˚C with 5% CO2. NO 
under physiological conditions converts to nitrite (NO2-), which induces formation of the 
azo dye that absorbs at 548 nm. Specific absorbance at 548 nm was measured and 
corrected with blank measurement and with absorbance at 690 nm with a Spectra Max 
M5 plate reader. 
Cell Viability Studies  
Bovine coronary venular endothelial cells (CVECs) were cultured in 
GIBCO®Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F-12) 
from Invitrogen (Invitrogen, Carlsbad, CA), along with 10% FBS, 100 U/mL penicillin - 
100 U/mL streptomycin - 0.25 mg/mL amphotericin B (Lonza, Walkersville, MD), and 
20 units/mL heparin (Midwest Vet Supply, Lakeville, MN). For cytotoxicity 
experiments, cells were trypsinized and quenched with media. Trypsin was removed 
after centrifugation at 250 G for 5 minutes. Resuspended cells were plated (10 x 103 
cells/well) in a 96-well plate coated with 1.5 % bovine gelatin. Cells were incubated at 
37 C in a humidified atmosphere containing 5% CO2 for 24 h to adhere. The medium 
was replaced with fresh medium 1 h prior to the addition of formulations at desired 
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concentrations. The cells were incubated with the formulations for 72 h. MTS combined 
reagent was added to each well (Cell Titer 96® Aqueous Non-Radioactive Cell 
Proliferation Assay, Promega Co., Madison, WI).  The cells were then incubated with 
the reagent for 2 h at 37 C in a humidified atmosphere containing 5% CO2 protected 
from light. Absorbance was measured at 490 nm using SpectraMax M5 (Molecular 
Devices Co., Sunnyvale, CA).  The cell viability was calculated based on the relative 
absorbance to the control-untreated cells.   
Experimental Details for Chapter VI 
The various structures reported in Chapter VI were prepared according to known 
procedures69,70,91-93 and modified as necessary. Crystals were obtained in general by the 
three layer technique. All structures have been deposited into the Cambridge 
Crystallographic Database and ascension numbers are given. Short descriptions of 
properties are given with each structure. 
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CHAPTER III  
COPPER (II/I)-PROMOTED LIGAND EXCHANGE AND NO RELEASE FROM 
DINITROSYL IRON COMPLEXES (DNICs) 
 
Introduction  
The discovery of dinitrosyl iron complexes, DNICs, as potential NO storage and 
delivery agents, has prompted the development of a distinct field in the DNIC area.21,94,95 
Although much is known about the synthesis, reactivity, and, to a lesser extent, the 
biochemistry of these complexes, the goal of developing their physiological or 
therapeutic potential requires an understanding of the interaction of the Fe(NO)2 unit 
with components of the physiological milieu. As more results accumulate regarding the 
interactions of the Fe(NO)2 unit, an interesting correlation between this unit and copper 
has been revealed. Such is highlighted by their respective interactions with glutathione-S 
transferase (GST) and S-nitrosothiols (RSNOs).18,53,61-63 The electronic similarity of 
these two units is demonstrated in thiolate/disulfide interconversion reactions which 
involve the redox couples, {Fe(NO)2}
9/10 and CuII/CuI.65,68,80 Furthermore, Cu and 
Fe(NO)2 in their two redox levels can form structurally analogous coordination 
complexes as showcased by tetramolecular and cluster compounds wherein the Cu and 
Fe(NO)2 units occupy analogous sites.
69-71,96 
Glutathione-S transferases represent a family of enzymes that serve as part of the 
cell detoxification mechanism by binding toxins to activated glutathione and functioning 
as transport proteins.13 These enzymes, found predominately in the liver, protect the cell 
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from harmful toxins such as carcinogenic metabolites and metal ions, by catalyzing the 
nucleophilic attack of glutathione (GSH) on these electrophilic substrates.73,74 In 2016, 
Ahmed et al. reported the effects of a range of metal ions as chloride salts (NaCl, KCl, 
FeCl2, LaCl2, MnCl2, CaCl2, MgCl2, NiCl2, ZnCl2, CdCl2, CoCl2, CuCl2, FeCl3, and 
AlCl3) on camel liver GST.
63 Of all the metals tested, CuII showed the greatest inhibition 
of enzyme activity, readily attributed to the strong binding affinity of CuII for the thiol 
groups on GST. Studies using GST from rat liver and mouse lung fibroblast cells have 
further proven the high affinity of CuII for GST, although no structural evidence for the 
binding of Cu to GST has been reported to date.61,97 Interestingly, in 2005, Cesareo et al. 
isolated and structurally characterized human GST P1-1 with the Fe(NO)2 unit bound to 
the active site via tyrosine.64 In this study, an exogenously prepared bis-glutathione 
DNIC, [(GS)2Fe(NO)2]
-, i.e. the oxidized,  {Fe(NO)2}
9 form, was introduced to the GST, 
resulting in replacement of one of the GS ligands with the tyrosine of the GST active 
site.64 Although it remains to be seen how the CuII (and other metals) binds to the GST, 
we note that the electronic correlation holds, in that the Fe(NO)2 unit is in the oxidized 
{Fe(NO)2}
9 state.  
The decomposition of the biological NO carriers S-nitrosothiols (RSNOs), also 
demonstrates a correlation between Cu and the Fe(NO)2 unit. Copper is known to 
facilitate the breakdown of RSNOs, yielding NO and disulfide, as shown in Scheme III-
1.53,54,98 A major argument supporting these studies is the attenuation of RSNO 
decomposition upon the addition of 2,9-dimethyl-1,10-phenanthroline (commonly called 
neocuproine), known for its high selectivity towards CuI. 53,54,98 Although neocuproine 
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does not as efficiently chelate Fe2+, Vanin, et al. reported that in the presence of NO(g), 
neocuproine does bind to iron, forming stable DNICs.18,59 The fact that neocuproine 
binds iron when NO is present (where previously it was assumed that neocuproine 
selectively bound CuI) presents the possibility that copper might not be the sole 
facilitator of NO release from RSNOs. Indeed, Vanin, et al. noted that either Fe2+ or Fe3+ 
ions accelerated the degradation of RSNO (where R = cysteine) concomitant with the 
appearance of a DNIC, where the source of the NO in the DNICs formed was traced to 
the RSNOs.18 The DNICs were identified by the appearance of the prototypical signals 
centered near g = 2.03, and assigned to either cysteine-containing (in the case where L-
cysteine was also added) or to phosphate-containing DNICs (when in phosphate 
buffer).23 Although not a direct correlation between Cu and Fe(NO)2, the formation of 
the DNIC in RSNO degradation suggests these two units might be at work in the same 
process, i.e. the breakdown of RSNO.  
The electronic similarities between the {Fe(NO)2}
9/10 and CuII/CuI redox couples 
with regards to thiolate/disulfide interconversion are also demonstrated in recent work 
by the M. Y. Darensbourg laboratories. A DNIC of the form [(sIMes)(SPh)Fe(NO)2], 
(where sIMes = 1,3- bis(2,4,6- trimethylphenyl)-imidazole and SPh = thiophenol) was 
found to undergo a reduction in the presence of CO(g) to form disulfide and the reduced, 
{Fe(NO)2}
10 [(sIMes)(CO)Fe(NO)2].
65  
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In a study that parallels the Darensbourg work outlined above (albeit with 
copper), Henkel et al. reported formation of disulfide, concomitant with CuII/I reduction, 
induced by addition of chloride ions.68 In this regard, CuII is known to be a potent 
oxidant for disulfide formation in proteins. For example, the metalloprotein responsible 
for the delivery of Cu to superoxide dismutase 1 (SOD1), is proposed to assemble 
cysteinyl thiolates resulting in disulfides between itself and the apo-Cu-SOD1, 
ultimately leading to the translocation of copper into the SOD1.80 
In addition to the electronic similarities between these two units, there are also 
examples of structural similarities that have been uncovered in studies of the binding 
affinities of metal thiolates as S-donor ligands to CuI and {Fe(NO)2}
10. Reaction of 
[Ni(bme-dach)Fe(NO)2(CO)] (where bme-dach = N,N′-bis (2-mercaptoethyl)- 1,4-
A 
B 
Figure III-1. Electronic similarities between Cu and Fe(NO)2 displayed in the 
{Fe(NO)2}
9/10 and CuII/CuI redox couples with regards to thiolate/disulfide 
interconversion.65 
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diazacycloheptane) with Fe(CO)2(NO)2 yields a complex containing two six-membered 
NiS3Fe2 cyclohexane-like rings in chair conformations and one eight membered 
Ni2S4Fe3 ring held within an incomplete adamantane-like cluster (highlighted in the 
structure in Figure III-2).70 
 
 
 
 
 
 
 
 
An analogous incomplete adamantane-like cluster is formed from the simple 
combination of CuICl with CuII(N2S2) (N2S2 =  bis(N,N’-2-mercapto-2-methylpropyl)-
1,5-diazocyclooctane), while the major product in this reaction as well as a similar 
reaction of CuICl and Ni(N2S2) realized the completed adamantane core.
69 An overlay of 
the two incomplete adamantane-like cores is shown in Figure III-2. As illustrated by the 
open circle, a vacant site exists wherein a fourth metal would be bound. This possibility 
Figure III-2. Simple depiction of the adamantane-like clusters containing a 
vacant site when M = CuII and M’ = CuICl or when M = NiII and M’ = 
Fe(NO)2. The two incomplete adamantane cores overlay well, as depicted in 
the structural overlay.69,70 
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was realized by CuI but not by {Fe(NO)2}
10. Preliminary computations suggested that 
the reason for this vacant site in the latter case is the steric constraint of the additional 
Fe(NO)2 unit.
70 
 
 
 
 
 
 
 
 
While CuI and {Fe(NO)2}
10 form cluster compounds with thiolates, the structural 
analogs of CuII and {Fe(NO)2}
9 reside in a harder donor environment. As shown in 
Figure III-3, tetrameric molecular squares of CuII and of {Fe(NO)2}
9 bridged by 
imidazole have also been isolated.71,96 In both cases, the corner atoms are comprised of 
either {Fe(NO)2}
9 or CuIIL, where L = 1,4,7-triazacyclononane).71,96 
In light of the correlation between Cu and the Fe(NO)2 unit, as well as the high 
concentration of copper in the cytosol, we have designed an experiment that explores the 
competition between Cu and Fe(NO)2 for a chelating agent, neocuproine, known to bind 
both. These reactions show redox changes and NO release, as neocuproine is transferred 
B A 
Figure III-3. Tetramolecular squares comprised of imidazole linkers in which 
either {Fe(NO)2} (A) or CuL (L = 1,4,7-triazacyclononane) (B) occupy the 
corners.  
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from the DNIC to the copper. The products of this complex reaction are identified and 
discussed below.  
Results and Discussion  
Synthesis and Characterization of the Neutral {Fe(NO)2}
10 [(neo)Fe(NO)2] (1) and the 
Cationic {Fe(NO)2}
9 [(neo)Fe(NO)2]
+ (1+) 
To explore DNIC reactivity with Cu, we chose the {Fe(NO)2}
10 DNIC, 
[(neo)Fe(NO)2] (1), where neo = 2,9-dimethyl-1,10-phenanthroline, a widely used 
copper chelator. Complex 1 was synthesized in a manner similar to that used by Kim, et 
al. in which neo was added to Fe(CO)2(NO)2, as shown in Figure III-3.
99  
A color change from orange red to dark red brown was observed, and the 
resulting solution of the air-sensitive product was characterized by IR and UV-Vis 
spectroscopies. The IR spectrum of the diatomic ligand region recorded in THF solution 
(blue spectrum shown in Figure III-4) revealed disappearance of the CO bands of the 
Fe(CO)2(NO)2 and a shift of the NO bands from 1761 and 1807 cm
-1 to 1648 and 1697 
cm-1 (1628 and 1692 cm-1 (KBr) as reported by Kim, et al.).99  
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Complex 1 is thermally stable in organic solvents in the absence of oxygen or 
added reagents, rendering it an ideal candidate to explore NO release. Additionally, we 
recently reported NO release from 1 in aqueous media in both the presence and absence 
of endothelial cells, making it one of the only examples of a reduced {Fe(NO)2}
10 
DNICs explored for NO release.100  
Oxidation of 1 by addition of 1 equiv of FcPF6 at -78˚C resulted in a shift in the 
NO bands from 1648, 1697 cm-1 to 1769, 1837 cm-1, presumably forming 
[(neo)Fe(NO)2]
+ (1+). The  large red shift (~130 cm-1, where ~100 cm-1 shift is expected 
Figure III-4. Reaction scheme for the synthesis of complex 1 and it’s oxidation to 
complex 1+. Also shown is the overlay of the ν(NO) IR spectra of complex 1 
(blue) and complex 1+ (red) in THF. 
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for a one electron oxidation) coupled with an increase in the separation between the 
bands corresponds well to what is observed in similar compounds such as  
(sparteine)Fe(NO)2, which shows a NO shift from 1622, 1679 cm-1 to 1746, 1814 cm-1 
upon oxidation.101 Although comparison of the IR spectra of 1 and (TMEDA)Fe(NO)2 
find the two N-donor ligands are nearly identical in electron-donating ability (((NO): 
1648, 1697 cm-1 (1) and 1648, 1698 cm-1 (TMEDA)Fe(NO)2), the (TMEDA)Fe(NO)2
+ is 
only observed as a short-lived intermediate,45 while 1+ remains for several hours in 
solution.  
The EPR spectrum of 1+ (watermark behind chemdraw of 1+, Figure III-4) 
exhibits a strong isotropic signal with g = 2.05 at 298 K, very close to that reported for 
(TMEDA)Fe(NO)2
+, albeit slightly higher than what is commonly reported for 
{Fe(NO)2}
9 DNICs (g = 2.03).45 Addition of cobaltocene to a solution of 1+ cleanly 
reduces it back to 1, as confirmed by IR spectroscopy (NO: 1648, 1697 cm-1) (Figure III-
3). These results align well with the reversible redox couple seen by cyclic voltammetry 
(E1/2 = -0.402 V vs. Fc/Fc
+ in CH3CN), which confirms that a cationic [(neo)Fe(NO)2]
+ 
species should be accessible by chemical oxidation.  
The oxidized version of 1 (1+) was earlier prepared by Lehnert, et al. from 
exposure of a mixture of a ferrous acetonitrile adduct and neocuproine to NO gas. The 
product 1+ was isolated and structurally characterized (Figure III-5).102 Though 1 has 
been previously synthesized and used in various studies,99 to our knowledge, it has not 
been structurally characterized. Slow diffusion of hexanes/ether into a DCM solution of 
1 afforded dark red crystals that were analyzed by X-ray diffraction. Complex 1 (as well 
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as its oxidized counterpart 1+) exhibit the pseudotetrahedral geometry typical of these 
complexes. The slight bend of the NO ligands is toward each other, adopting the well-
known “attracto” conformation, which is defined by smaller O-Fe-O angles as compared 
to the N-Fe-N angles, in the planar FeN2O2 unit.  
 
 
 
 
 
 
 
XRD-derived structures of 1 and 1+ along with key metric parameters are given 
in Figure III-5. Comparison of these parameters trend as expected.  
+ 
 
Figure III-5. XRD-derived structures of 1 (left, this work) and 1+ (right)102 
given as ball and stick representations. Key metric parameters of each are 
given below the structures. 
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The average Fe-NNO bond lengths are slightly longer for 1+ than seen in 1 (1.675 (6) Å 
for 1+ and 1.649 (1) Å for 1) while the average N-O bond length is shorter in the case of 
1+ (1.176 (8) Å for 1+ and 1.200 (1) Å for 1), both of which are consistent with 
decreased  backbonding from the NOs in 1+.102 The NNO-Fe-NNO angle remains about 
the same in each at 169˚.  
The N(3)-Fe-N(4) angle of 79.7(1)˚ of 1 is slightly smaller than the N(3)-Fe-N(4) 
angles seen in the other complexes with similar ligand sets (TMEDA)Fe(NO)2 (82.57˚) 
and (sparteine)Fe(NO)2 (84.03˚).101 In all cases, the distorted geometry can be attributed 
to the strain effect of the chelating ligand.101 The NO ligands of 1 are slightly bent with 
an average Fe-N-O angle of 169˚, which aligns well with the angles seen in other 
{Fe(NO)2}
10 DNICs, for example the bis-imidazole (Imid-Me)2Fe(NO)2 (168˚)jen, 
(TMEDA)Fe(NO)2 (168˚), and (sparteine)Fe(NO)2 (164˚).101  
 
 
 
 
 
 
 
Figure III-6. Reaction of 1 with CuI salts to form the known complex 
[Cu(neo)2]
+ and NO (g). 
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Reactivity of 1 with CuX (where X = Br -, Cl -, PF6 
-)  
To begin investigating how copper might interact with a DNIC in vivo, we 
consider the main environments in which the two might come in contact. Firstly, 
considering the intracellular environment is reducing, i.e. a high concentration of 
glutathione, any interaction between copper and Fe(NO)2 within the cell would likely 
involve CuI.72 Hence, we first explored the reaction between CuI salts and 1, a rather 
simple yet effective reaction model. 
Complex 1 was dissolved in DCM and treated with a DCM solution of CuX (X = 
Br -, Cl-, PF6 
-) (2:1 stoichiometry). Most likely due to the poor solubility of copper salts 
in DCM, the reaction proceeded slowly. During the course of the reaction, NO gas was 
released, as confirmed qualitatively by an NO trapping agent, [Fe(bme-daco)]2, (where 
bme-daco = N,N′-bis (2-mercaptoethyl)- 1,4-diazacyclooctane) which converts to (bme-
daco)Fe(NO) upon reaction with NO(g) ((NO): 1648 cm-1).92 In the absence of copper, 1 
remains stable and no NO(g) formation is observed, indicating that copper does indeed 
play a role in NO release. The amount of NO released after 12 h correlated with the 
solubility of the starting copper salts. Solubility for the copper salts in DCM follows the 
trend [Cu(CH3CN)4]PF6 > CuBr > CuCl, while the percentage of NO released is 97%, 89 
% and 40%, respectively, after a 12 h stir.  
Although the fate of the Fe remains unknown in these reactions, the copper 
product was readily identified. After stirring overnight, all reactant NO bands 
disappeared, and no new IR-active species formed. Additionally, the solution changed 
color in all cases to a bright orange red, indicating the formation of the well-known tetra-
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coordinated copper complex [Cu(neo)2]
+; this product was confirmed by both its 
characteristic UV-vis spectrum and Mass Spectrometry. The ESI mass spectrum showed 
a single isotopic bundle at 479 m/z, which matches both the calculated and literature 
reported values for [Cu(neo)2]
+. Coppens et al. have carried out extensive studies on the 
solid state structures of [Cu(neo)2]
+, finding that it can adopt a variety of conformations 
with various degrees of rocking or flattening, depending upon the counter anion used.88 
For example, when the counter ion is PF6
-, the X-ray crystal structure shows a distortion 
by flattening toward a more square planar geometry, while with the BF4
- counter ion, a 
rocking distortion is more prominent, leading to a trigonal pyramidal geometry. 
However, the idealized ground state geometry of all the [Cu(neo)2]
+ complexes is 
comprised of a pseudotetrahedral, D2d-symmetric arrangement of the phenanthroline 
ligands around the copper center.88 For this D2d symmetry, four low-energy singlet to 
singlet transitions are possible,103 but only one has its dipole moment operator along the 
2-fold axis.88 Thus, there is only one symmetry-allowed transition, which is seen at 
around 450 nm in the solution absorption spectra.  
Overall, the reaction of CuBr with 1 is a ligand exchange reaction in which the 
neo ligand is transferred to the CuI, while the Fe(NO)2 unit most likely falls apart due to 
the lack of available coordinating ligands. While it is unlikely that the halide would 
attack the electron rich {Fe(NO)2}
10 unit, the possibility of such a reaction was 
nonetheless tested. A reaction similar to that shown in Figure III-6 was carried out as 
described in the previous paragraph, but with NaBr replacing the CuX. Even after a 24 h 
stir, 1 remained unreacted (vid IR spectroscopy) and NO release was not observed. We 
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also note the reaction worked when the copper source was Cu(CH3CN)4PF6, 
demonstrating that the halide is not essential in the reaction mechanism.  
Likewise, when Fe(CO)2(NO)2 (instead of 1) is reacted with Cu
I, no change in 
the IR spectrum was observed, even after hours of stirring. Hence, without the neo 
ligand present, the DNIC appears to be inert (or at least less reactive) toward the CuI 
salts. The reaction of 1 with CuI can thus be best described as a ligand exchange 
reaction, where the driving force appears to be the stability of the product [Cu(neo)2]
+. 
Changing either of the starting materials in this reaction, i.e. replacing either 1 with 
Fe(CO)2(NO)2, or CuX with NaBr, shows no reaction.  
 
 
 
 
 
 
Figure III-7. Reaction of 1 with CuBr2 exhibits both a redox reaction and ligand 
transfer, yielding a mixture of products. The products shown are those that have 
been identified. Complex 6 has been observed spectroscopically and will be 
discussed in the section on identification of the new DNICs products. 
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Reactivity of 1 with CuX2 (where X = Br 
-, Cl -)  
Though evidence exists for transport of intact DNICs into the cell,104 the 
possibility also remains that DNICs might degrade before entering the cells. Since 
exogenous addition of DNICs as therapeutics is a translational aspect of these studies 
both by us and others, developing a clear understanding of interactions at the cell 
surface, or en route to the cell, is of crucial importance. Hence, we employed a similar 
strategy to that outlined the section on CuI reactivity, but this time using CuX2, where X 
= Cl -, Br -.  
Unlike the simple ligand exchange reaction with CuI, reaction of 1 with CuII salts 
appears to be a one-electron redox process accompanied by ligand exchange. With a 
much lower redox potential of -0.36 V, 1 is readily oxidized by the CuBr2 (E1/2 = 0.18 V, 
Figure III-8) to yield a mixture of oxidized DNIC products and the CuI species 
[Cu(neo)2]
+. The cyclic voltammograms of the two reactants, as well as the copper 
products are given in Figure III-8 and the redox potentials given assume reversibility, 
although the event is not rigorously reversible as classically defined.  
[(neo)
2
Cu]
+
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With a 2:1 ratio of 1:CuX2 (X = Cl
-, Br-), the reaction is complete within an hour, 
forming a dark red-brown solution with CuBr2 and an orange brown when CuCl2 is used. 
The IR spectrum of this solution shows the growth of two new NO bands at 1792 (s), 
1765 (sh), 1730 (s), 1705 (sh) cm-1 (when X = Br-), concomitant with the disappearance 
of 1. Both the pattern and the position of the bands suggest the formation of two 
CuBr
2
 
E
1/2
 = 0.18 V 
(2) 
 E
1/2
 = - 0.21 V 
(1) 
E
1/2
 = - 0.36 V 
[(neo)2Cu]+ 
E
1/2
 = 0.43 V 
Figure III-8. Cyclic voltammograms of 2 (maroon, top), [Cu(neo)2]
+ (purple, 
second from top), 1 (green, third from top) and CuBr2 (brown, bottom) all in MeCN.  
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oxidized DNICs, most likely containing bromides. Attempts to separate, isolate and 
characterize these products were unsuccessful. Hence, we developed alternate synthetic 
routes (discussed in the next section) to support the presumed identity of the DNIC 
products. In addition to the formation of new DNICs, the production of NO was also 
detected (via trapping with [Co(bme-dach)] as described earlier). Both mass 
spectrometry and UV-vis spectroscopy confirmed that the sole copper product that 
formed was the [Cu(neo)2]
+(Figure III-9). 
When X = Cl -, the IR spectrum of the reaction mixture of 1 and CuCl2 shows the 
complete disappearance of the (NO) bands of 1 and no new bands appear. The UV-vis 
spectrum exhibits two distinct absorptions at 353 and 845 nm. X-ray analysis of the 
green crystalline product formed when CuCl2 is used revealed a trigonal bipyramidal 
copper complex [(neo)CuCl2•H2O] (4). However, we chose the CuBr2 system to study in 
depth as discussed next.   
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When the reactant stoichiometry was changed to a ratio of 1 to 1 (i.e., an excess 
of CuX2), an additional Cu product was formed, along with all of the products observed 
above. In this case, the reaction occurred upon mixing, as evidenced by the immediate 
color change to a dark red-brown. An IR spectrum of the reaction mixture recorded 
Figure III-9. +ESI-MS of the mixture produced from reaction of 1 with CuPF6 
(reaction stoichiometry 2:1). The isotope bundle for the parent ion [(neo)2Cu]
+ is 
centered at 479 m/z. The top spectrum shows the full range, while the lower 
spectrum is zoomed in to show the pattern for the parent isotopic bundle. The UV-
vis spectrum of 1 (red) with the product mixture from the reaction shown in Figure 
III-1 (blue) is displayed as an inset and shows the appearance of the absorbance at 
454 nm.  
 
67 
 
 
within 2 min of mixing showed complete disappearance of the NO bands of 1, and 
appearance of the new bands at 1792 (s), 1765 (sh), 1730 (s), 1705 (sh) cm-1. An 
additional copper product, besides the [Cu(neo)2]
+, was observed via UV-vis 
spectroscopy. In the case of X = Br -, there is a distinct absorption band that appears at 
567 nm (Figure III-10), which corresponds to the pseudotetrahedral [(neo)CuBr2] (2), 
confirmed by comparison of the UV-vis spectrum obtained from this reaction with that 
of 2 synthesized via an alternate route.  
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Wavelength (nm) 
Figure III-10. Overlay of the UV-vis spectra of 2 (blue), 1 (red) and [(neo)2Cu]
+ 
(green). The top spectrum is of the reaction mixture of CuBr2 and 1. 
(A) 
(B) 
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Figure III-10 B shows an overlay of the two copper products, [(neo)2Cu]
+ (green) 
and 2 (blue) , along with that of 1 (red). As can be readily seen, the absorption band at 
567 nm that appears in the CuBr2 and 1 product mixture (Figure III-10 A) can be 
attributed to the formation of 2. Mass spectrometry further confirmed the formation of 
both [(neo)2Cu]
+ and 2 with two main isotopic bundles centered at 351 m/z (2 – Br -) and 
479 m/z ([(neo)2Cu]
+) (Figure III-11). 
 
 
 
 
 
 
 
 
 
 
 
Ford et al. reported the structure of [(neo)2Cu(H2O)]
2+, which readily converts to 
the CuI analog, [(neo)2Cu]
+.105 This tendency to convert to the reduced species, 
[(neo)2Cu]
+, along with the stability of the [(neo)2Cu]
+, might account for the high 
Figure III-11. +ESI-MS of the product mixture from reaction of 1 with CuBr2 
(reaction stoichiometry 1:1) (see Figure III-7). Two copper containing products 
were identified, namely [(neo)2Cu]
+  (m/z = 479 m/z) and 2 (m/z = 351, 2 – Cl-).   
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intensity of [(neo)2Cu]
+ compared to that of 2 in the mass spectrum. Detailed analysis of 
each of the products formed in this reaction are given in the sections that follow. 
Structural Analysis of the Complexes 2-5 
Complexes 2 and 3 
In addition to being formed in the reaction shown in Figure III-7, Complex 2 was 
synthesized directly from addition of the neocuproine ligand to CuBr2. XRD analysis of 
the dark red needles obtained from this reaction revealed a pseudotetrahedral copper 
center coordinated by two bromides and the nitrogens of the neocuproine (Figure III-12 
A). An identical structure was obtained from the reaction of CuBr2 and 1.  
 
 
 
 
 
 
 
 
The geometry about the CuII center of 2 is pseudotetrahedral whose dihedral 
angle, defined as the intersection between the CuN2 and CuBr2 best planes, is 64.93˚, 
indicating a twist of 25.07˚ from perfect tetrahedral geometry. The N(1)-Cu-N(2) angle 
A B 
Figure III-12. The ball and stick representation of 2 (A) and its dimeric form, 3 (B). 
Hydrogens have been omitted for clarity. 
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of 83.5˚ is comparable to the N-Fe-N angle seen in the 1 and 1+, but slightly larger than 
the N(1)-Cu-N(2) angle of 81.2˚ in a similar complex, (phen)CuBr2 (phen = 1,10-
phenanthroline).106 Although the only difference in these two ligands is the methyl 
groups on the 2 and 9 positions of the ortho-phenanthroline, the geometry adopted by 
(phen)CuBr2 is planar, and forms a polymer with ladder-like bridging geometry.
106  
Other N2CuBr2 complexes, such as where N2 = cyclohexane-1,2-diamine, also adopt a 
square planar geometry for the asymmetric unit and form a coordination polymer.107 
However, the bite angle in the case of N2CuBr2 (N2 = cyclohexane-1,2-diamine) is 83.7˚, 
which is nearly identical to that of 2.107 From this, it appears that neocuproine prevents 
the coordination polymer formation that is commonly seen in other bidentate, N2 
ligands. Indeed, the Cl-analog of 2, synthesized by Wang and Zhong, maintains a 
distorted tetrahedral coordination, with an N(1)-Cu-N(2) angle of 81.6˚, and does not 
show polymer formation.108 The Cu-N bond lengths of 2.028 Å and 1.984 Å in 2 
correspond well to those seen in the previously mentioned N2CuBr2 compounds, which 
range from 2.012 Å to 2.048 Å.106,107 In each case, one Cu-N bond is always shorter than 
the other.  
Complex 3, which co-crystalizes with 2, is simply a dimer of two identical units 
of 2. Each CuII center is coordinated by the two nitrogens of the neocuproine ligand, one 
terminal bromide and one bridging bromide. The average Cu-N distance is 2.109 (2) Å, 
which is slightly little longer than the average Cu-N bond in 2 (2.007 (2) Å). The 
terminal Cu-Br bonds are also longer in 3 compared to 2, 2.4128(5) and 2.3576 (5) Å, 
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respectively. The N-Cu-N angle of 79.93 (8)˚ in 3 is also more pinched than it is in 2 
(83.44(9)˚).  
Furthermore, comparison of 3 with two similar halide-bridged copper species, 
(-Br)2[Cu(neo)]2 and (-Cl)2[Cu(DPS)Cl]2 (DPS = Di(2-pyridyl)sulfide) shows that all 
parameters, besides the Cu-Cu distance and the N-Cu-N angles, are nearly identical.109 
The Cu-Cu distance in 3 is 3.6773(6) Å, very close to that found for (-
Cl)2[Cu(DPS)Cl]2  (3.69 Å). The (-Br)2[Cu(neo)]2 derivative of 3, lacking only the 
terminal bromides present in 3, had a much shorter Cu-Cu distance at 3.097 Å. The N-
Cu-N angle of 79.93(8) Å in 3 is essentially identical to the (-Br)2[Cu(neo)]2 at 80.3 
(2)˚.  
This dimer appears to be a product of crystallization rather than a separate 
product in solution. The UV-vis spectrum of the crude reaction mixture of neocuproine 
and CuBr2 is identical to that of the spectrum of the isolated crystals of 2 (blue spectrum 
in Figure III-7 B). Furthermore, no dimer was observed in mass spectrometry.  
Complex 4 
Complex 4 exhibits almost perfect trigonal bipyramidal geometry with  = 0.914. 
Here the copper center is coordinated by the bidentate-bound neocuproine ligand, two 
chlorides and a water molecule. 
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Other similar five-coordinate copper complexes of the N2CuCl2O-type tend to 
adopt more square pyramidal geometry, with tau values from 0.03-0.06.109,110 Complex 4 
contains a N(1)-Cu-N(2) bond angle of 79.8˚, a 3.7˚ decrease in bite angle from that of 
complex 2, but nearly identical to that seen in complex 1. The four-coordinate analog of 
complex 4 (complex 4 without the water), displays a N(1)-Cu-N(2) angle of 81.6˚.108 The 
Cu-Cl bond distances are 2.303 Å and 2.206 Å, which fit well into the expected range of 
2.242-2.560 Å seen in similar compounds.109,110 The Cu-O bond length of 1.959 Å is 
slightly lower than the Cu-O bonds of the two analogous N2CuCl2O compounds 
(1.984(2) Å when N2 = DPS and 1.9864(15) Å when N2 = bis(tetrazolyl)amine).
109,110  
  
Figure III-13. The ball and stick representation of the trigonal bipyramidal 
complex 4. Hydrogens have been omitted for clarity. 
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EPR Analysis of the Complexes 2-5 
The EPR spectra of DCM solutions of complexes 2 and 4 were measured at both 
77 and 3.6 K, as shown in Figure III-14.  
 
 
 
 
 
 
 
Each spectrum displays a broad isotropic signal at g = 2.123 for 2 and g = 2.127 
for 4. The hyperfine splitting is on par with background noise and is hardly 
distinguishable. With two naturally abundant isotopes of I = 3/2, 63Cu (69.09 %) and 
65Cu (30.91 %), each copper isotope could theoretically show four line hyperfine 
A B 
C D 
 
Figure III-14. X-band EPR spectrum of complex 2 in DCM at 3.6 K (A) and 77 K 
(B) and of complex 4 in DCM at 3.6 K (C) and 77K (D). 
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splitting. Although the majority of four-coordinate Cu(II) complexes show a four line 
hyperfine splitting, there are several examples described in the literature in which the 
hyperfine features are not resolved. Particularly pertinent examples include four-
coordinate Cu(II) complexes with derivatized phenanthroline ligands, obviously similar 
to neocuproine.111 Neither [Cu(TMP)2](ClO4)2 (TMP = 3,4,7,8-tetramethyl-1,10-
phenanthroline) or [Cu(DIP)2](ClO4)2 (DIP = 4,7-diphenyl-1,10-phenanthroline) showed 
copper hyperfine features and both gave broad EPR spectra.111 The broadening was 
hypothesized to arise from  stacking and non-covalent interactions between the 
phenanthroline ligands. Although such interactions are prevalent for phenanthroline 
ligands, no additional evidence was given to support such a case and no evidence for 
aggregation was observed in the ESI-MS, UV-vis or HPLC.111 Complex 2, however, can 
dimerize, at least upon crystallization, to form its dimeric counterpart, 3. The Cu-Cu 
distance is 3.6773(6) Å in 3, likely too great for spin coupling. Hence the broadening 
observed in the spectrum of 2 could be due to some formation of 3.  
In another report, a series of bis-pyrrolate-imine copper(II) complexes showed 
EPR spectra similar to that obtained for 2 and 4, i.e., the hyperfine coupling was not well 
defined and can almost be assumed to be background noise.112 In this particular study, 
the copper hyperfine splitting decreased with decreasing ligand-field transition energies.  
It is difficult to differentiate the exact number of hyperfine and super-hyperfine 
features present in the spectra displayed in Figure III-14. In addition to the expected 
copper hyperfine, 2 and 4 each contain halides, as well as nitrogen ligands, that could 
theoretically give multiple super-hyperfine features. Both bromine and chlorine have 
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nuclear spins of I = 3/2, which would each introduce another four line splitting on top of 
the copper hyperfine.  If nitrogen hyperfine splitting is also present, we would expect to 
see a splitting pattern possibly even in the hundreds. Considering the number 
paramagnetic centers, magnetic interactions between these centers is also a likely reason 
for the poor resolution of the hyperfine features.113 
Identification of the New DNIC Products 
The reaction of CuBr2 and 1 yields two different DNIC products, as shown in 
Figure III-7. Amongst the many possibilities for the identity of these products, two likely 
products come to mind, namely (-Br)2[Fe(NO)2]2 and a monomeric anion, 
[Fe(NO)2Br2]
-. Although all attempts to isolate the DNIC products from this reaction 
mixture have proven unsuccessful, we developed several alternate synthetic routes to 
directly synthesize the hypothesized DNICs and spectroscopically prove their identity. 
The following section outlines our analysis in this regard. 
Synthesis of (-Br)2[Fe(NO)2]2 
Addition of bromine to a freshly prepared THF solution of Fe(CO)2(NO)2 
resulted in a color change from orange red to dark brown (reaction shown in Figure III-
15). The IR spectrum revealed disappearance of the CO bands of the Fe(CO)2(NO)2 at 
2090, 2035 cm-1, and a shift of the NO bands from 1808 and 1763 cm-1 to 1816 and 1769  
cm-1 (Figure III-16).  
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Although a dimeric species is expected, the band separation of 47 cm-1 falls into 
the range of the typical monomeric DNICs (~40-60 cm-1) and above the expected range 
for dimeric DNICs (15-38 cm-1). Attempts at crystallization proved unsuccessful, 
however we conclude that the species formed in this reaction is not one of the DNICs 
formed in the CuBr2 reactions, as the (NO) stretches do not overlay. Additionally, this 
Figure III-15. The synthesis of (-Br)2[Fe(NO)2]2 can be achieved by oxidative 
addition of Br – (from either Br2 or CuBr2) to Fe(CO)2(NO)2. 
1816 
1769 
Figure III-16. IR spectrum, (NO) region, of (-Br)2[Fe(NO)2]2 in hexanes. 
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product was soluble in hexanes while the DNIC products formed in the CuBr2 reaction 
are not. 
Synthesis of [Fe(NO)2Br2]
-(5) 
The monomeric anion [Fe(NO)2Br2]
-
 (5) was prepared from NaBr as shown in 
Figure III-17. Under an argon atmosphere, [Na-18-crown-6-ether][Fe(CO)3(NO)] and 2 
equivalents of NOBF4 were stirred with NaBr for 120 min in THF. The reactant NO 
bands disappeared with concomitant appearance of new NO bands at 1780, 1712 cm-1.  
 
 
 
 
 
 
 
 
Complex 5 was isolated as a sodium crown ether salt from slow diffusion of 
hexanes into a THF solution. The structure is discussed below. As displayed by the blue 
spectrum in Figure III-18, the (NO) bands of 5 perfectly overlay the shoulders seen in 
the IR spectrum from the reaction of 1 and CuBr2. 
Figure III-17. Reaction scheme of the synthesis of [Fe(NO)2Br2]
-
 from NaBr. The 
same reaction was carried out with CuBr replacing the NaBr, although the (NO) 
stretches did not match those of [Fe(NO)2Br2]
-. The product of the CuBr reaction 
has yet to be positively identified. 
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Hence, we assign one of the DNIC products formed in the reaction of 1 and 
CuBr2 to be 5. Furthermore, UV-vis analysis of 5 showed two main absorption bands at 
690 and 520 nm, both of which appear in the spectrum of the reaction mixture of 1 and 
CuBr2. X-ray analysis of the dark brown crystals of 5 confirmed the formation of the 
pseudo-tetrahedral DNIC, [Fe(NO)2Br2]
- as its sodium 18-crown-6 ether salt.  
Figure III-18. Overlay of the IR spectrum of 5 (blue) with that of the new DNICs 
formed in the reaction of 1 with CuBr2. 
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Figure III-19. The crystal packing diagram of 5 showing two of the DNIC units per 
unit cell (top). The ORTEP of 5 (bottom) with thermal ellipsoids drawn at 50% 
probability. Hydrogens have been omitted for clarity.  
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Complex 5 contains a tetrahedral iron center coordinated by two bromides and 
two nitrosyls (Figure III-19). Each unit cell houses two of the DNIC units, as shown at 
the top of Figure III-19. To our knowledge, the only other halide DNIC that has been 
structurally characterized is the iodide-containing DNIC [I2Fe(NO)2]
-.114 The Fe-X 
bonds in 5 are ca. 0.2 Å shorter that those in the iodide case, as expected, while the Fe-N 
bond distances are about the same (avg. 1.73 Å for each). The N-Fe-N angles are almost 
exactly the same for each (114.3(3)˚ for 5 and 114.03(13)˚ for [I2Fe(NO)2]-).114 The 
average Fe-N-O angle is 165.9(6)˚ for 5 and 164.9(3)˚ for [I2Fe(NO)2]-.114   
Synthesis of Complex 6 
Having confirmed the identity of one of the DNIC products formed in the 
reaction of 1 and CuBr2, we are left with one unidentified product, observed via IR 
spectroscopy with (NO) bands at 1792 and 1730 cm-1. Speculating that this product 
might be similar to 5 but with perhaps a Cu+ counterion (or even a Cu-DNIC product), 
we carried out the reaction shown in Figure III-17 but with CuBr instead of NaBr. The 
resulting IR spectrum is shown as an overlay with the IR spectrum of the reaction 
mixture of CuBr2 and 1 (Figure III-20).  
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The NO band at 1730 cm-1 perfectly overlays with that of the CuBr2 and 1 
product mixture, while the second band at 1792 cm-1 shows an interesting split. We 
propose that this product might be a Cu-bridged DNIC species, although efforts to 
structurally characterize the product have thus far been unsuccessful. 
Conclusions and Closing Comments 
Building on the premise that copper and the Fe(NO)2 unit can both occupy 
structurally equivalent sites, we designed a study that explored the competition of the 
copper and Fe(NO)2 for neocuproine. Consistent with the strong affinity of neocuproine 
for Cu(I), reaction of CuI sources with [(neo)Fe(NO)2] resulted in near quantitative 
formation of the well-known bis-neocuproine cation, [(neo)2Cu
I]X, where X = Cl-, Br-, 
PF6
-, and release of gaseous NO. For the reaction of [(neo)Fe(NO)2] and Cu(II), 
specifically CuBr2, redox processes were also involved and resulted in a mixture of 
copper and DNIC products and NO gas. A portion of the copper was reduced, yielding 
 
Figure III-20. Overlay of the IR spectrum of 6 (blue) with that of the new DNICs 
formed in the reaction of 1 with CuBr2. 
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the [(neo)2Cu
I]+ cation, while the remainder of the copper formed the new Cu(II) 
complexes [(neo)CuBr2] or [(neo)CuCl2H2O]. Interestingly, two different oxidized 
{Fe(NO)2}
9 DNIC products were also observed via IR spectroscopy. One of the DNICs 
was isolated as the sodium 18-crown-6 ether salt of Br2Fe(NO)2
-. While this study 
highlights the electronic and structural connections between the CuII/I, d9/10, and the 
{Fe(NO)2}
9/10 redox couples and electronic configurations, the findings have generated 
many questions whose answers would greatly enhance our understanding of DNICs. The 
next several paragraphs will address some of the more obvious questions that have been 
raised and will offer direction for future studies in this area. 
The release of NO in these reactions highlights an important point: the use of 
copper to promote NO release. To our knowledge, copper has never been explored as a 
promoter for NO release from DNICs prior to this work. However, considering that it 
catalyzes the decomposition of RSNOs which results in NO release, it is plausible that 
copper might be at play in endogenous DNIC decomposition. The reaction pathways for 
RSNO decomposition involve copper forming an adduct with the RSNO, followed by 
release of NO and the thiyl radical. Considering that sulfurs in thiolate-containing 
DNICs have available lone pairs, interaction with copper, resulting in copper thiolate 
complexes and the decomposition of the DNIC with release of NO (due to the lack of a 
supporting ligand for the Fe(NO)2 unit) is reasonable.  
We note that our ligand choice for this study, namely neocuproine, may skew the 
results towards ligand exchange due to the high affinity of copper for neocuproine. Such 
a result brings with it multiple questions to be addressed in the future. Will copper 
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facilitate the release of NO from DNICs containing ligand sets other than neocuproine, 
for example thiolates, N-heterocyclic carbenes, and/or other N-donor ligands? 
Due to solubility issues with the copper salts that were used in our study from 
Chapter III, no kinetic data could be obtained. However, by using more soluble copper 
sources, such data could be gathered. Because cellular copper is normally found within a 
coordination sphere rather than as a salt, a more realistic model would be to use copper 
complexes of histidine, cysteine or glutathione. Such a system, coupled with 
biocompatible DNICs, for example those covered in Chapter V, would provide a 
realistic biomimetic study for the effect of copper on NO release from DNICs. 
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CHAPTER IV  
INTERPLAY BETWEEN THE TWO BIOLOGICAL NO CARRIERS/STORAGE 
UNITS: S-NITROSOTHIOLS AND DINITROSYL IRON COMPLEXES 
 
Introduction 
As was briefly discussed in chapter I, nitrosylation of iron-sulfur clusters results 
in the formation of both protein-bound and low molecular weight DNICs, including 
Roussin’s red esters (RREs), through degradation of the [2Fe−2S] and [4Fe−4S] 
clusters.15 The nitrosylation of the iron-sulfur clusters is important in the regulation of 
intracellular iron levels, for it stimulates the binding of iron responsive proteins.115 
However, iron-sulfur clusters can also be regenerated from these DNICs and RREs. 
Ding et al. reported that DNICs formed from NO-modified ferredoxin in Escherichia 
coli (E. coli) cells can be directly transformed back into the ferredoxin cluster by 
cysteine desulfurase (an S-donor) and L-cysteine.116 
Multiple studies have provided EPR evidence for the formation of DNICs from 
the interaction of NO with iron-sulfur clusters in proteins including succinate 
dehydrogenase, nitrogenase, succinate-Q reductase, mitochondrial aconitase, cytosolic 
aconitase, endonuclease III, SoxR and mammalian ferrochelatase.104,117-123 However, a 
complete understanding of this reaction, specifically within a biological setting, has yet 
to be elucidated. One of the more insightful studies regarding this reaction was carried 
out by Cowen et al. wherein the degradation products of a high potential iron protein 
(HiPIP) were analyzed upon exposure to NO.124 As observed by UV-vis, EPR and NMR 
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spectroscopies, as well as ESI-mass spectrometry, the protein-bound [4Fe-4S] cluster 
converted to a protein-bound DNIC with two Fe(NO)2 units per cluster. 
Lippard et al. developed small molecule protein analogs of the metalloprotein 
active site to give insight into the interactions of NO with iron-sulfur proteins.90 When 
added stoichiometrically (1:1), the trityl-S-nitrosothiol reagent, Ph3CSNO, 
mononitrosylated each of the four irons of the cluster. With addition of an excess of 
Ph3CSNO, an additional nitrosyl was added to three of the four iron centers, forming 
dinitrosyl iron units on the cuboidal FeS scaffold.90 This particular study provided an 
interesting example of the interaction between the two biological NO carrier/storage 
agents, namely DNICs and RSNOs. Considering that NO is rarely free in vivo, an RSNO 
is a very plausible choice for a biologically relevant source of NO. Hence, further 
investigation into the interactions of DNICs and RSNOs is warranted. 
The formation of DNICs from RSNOs was observed by Vanin et al., discussed in 
detail in Chapter I. Therein, DNIC formation was observed upon introduction of RSNOs 
to iron-containing buffer solutions.18 Liaw et al. have noted the reverse of this process, 
i.e., formation of RSNOs from DNICs.42 When a chelating disulfide was added to the 
{Fe(NO)2}
9 DNIC [(NO)2Fe(C12H8N)2], (C12H8N = carbozolate), a mononitrosyl iron 
species was formed, along with RSNO.42  
Apart from the reports reviewed above, the interaction between DNICs and 
RSNOs has not been thoroughly studied. Hence, we took two simple DNICs, both in the 
reduced {Fe(NO)2}
10 form, namely Fe(CO)2(NO)2 and [(neo)Fe(NO)2] (neo = 2, 9-
dimethyl-1,10-phenanthroline) and studied their reaction with trityl-S-nitrosothiol 
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(Ph3CSNO). Unique to our study is the use of the reduced {Fe(NO)2}
10 DNICs. 
Additionally, Ph3CSNO was judiciously chosen for its stability, as well as its ability to 
act as a sulfide donor. The Ph3CSNO thus has the potential of serving as a sulfide donor 
and nitrosylating agent, providing a model, albeit crude, for biological interactions 
between RSNOs and reduced DNICs in the presence of cysteine desulfurase. This 
chapter describes our findings. 
Synthesis and Characterization 
Figure IV-1 presents the synthetic routes used to form complexes 1 and 2. Each 
reaction, along with the products formed, will be discussed in this section. Figure IV-1 
(b) will be addressed first, followed by (a) and then (c).  
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Room temperature reaction of the orange THF solution of Fe(CO)2(NO)2 with 
the green THF solution of Ph3CSNO in 1:1 stoichiometric ratio results in a dark red 
solution following a 1 h stir. The disappearance of the CO stretching bands along with a 
shift in the NO IR bands from 1807 and 1761 cm-1 to 1786 and 1751 cm-1 indicated the 
complete conversion of Fe(CO)2(NO)2 to 1 (Figure IV-2 A). Nitric oxide was also 
released and was detected using the setup shown in Figure IV-2 B, wherein the reaction 
described above is inititated within the inner tube, while the NO-trapping agent, 
[Fe(bme-daco)]2 (bme-daco = N,N′-bis (2-mercaptoethyl)- 1,4-diazacyclooctane) is 
present in the outer tube. When NO is released, it is taken up by the [Fe(bme-daco)]2, 
Figure IV-1. Synthesis of complexes 1 and 2. Only those products that were 
identified are listed. The NO produced was trapped as [Fe(bme-dach)(NO)] (bme-
dach = bis(N,N’-2-mercapto-2-methylpropyl)-1,5-diazocycloheptane). 
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resulting in formation of the mononitrosyl species [Fe(bme-daco)NO], as evidenced by a 
distinct color change from brown to green and the appearance of a single NO IR band at 
1648 cm-1.91 
 
 
 
 
 
 
 
 
 
The NO IR bands of 1 show a peak separation (NO) similar to that expected for 
Roussin’s red ester (RRE)-type DNICs. As tabulated by Liaw et al., the separation 
generally falls within the range of 15-38 cm-1.21 For 1, the NO is 35 cm-1, which is 
within the expected range for RRE-type DNICs and below that seen in the typical 
monomeric DNICs (NO: ~ 40-60 cm-1).21 However, the pattern is rather unusual. For 
RRE-type DNICs the two NO bands are typically of equal intensity, while the 
monomeric DNICs show the reverse of the pattern seen for 1, i.e. the first band has a 
lower intensity than the second band.  
NO 
B A 
Figure IV-2. IR spectra, NO region, of 1 in THF (red) and Fe(CO)2(NO)2 (gray) 
(A). A diagram of the typical setup used to detect the release of NO during the 
synthesis of 1 (B). 
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Under an inert atmosphere and at -35˚C, 1 is stable in the solid phase for several 
weeks. However, stability in the solution phase and towards oxygen was not tested. As 
would be expected from the presence of the trityl groups, 1 is soluble even in non-polar 
solvents such as hexanes. 
X-ray quality dark red crystals of 1 were grown by slow evaporation of a 
concentrated hexane solution under an inert atmosphere. The molecular structure that 
was obtained from XRD analysis is shown in Figure IV-3 A.  
 
 
 
 
 
 
 
 
This cluster contains a S3[Fe(NO)2]4 core, where the two end sulfurs are 2-
binding Ph3CS thiolates, while the inner sulfur is a bridging sulfide. The three S 
alignment is roughly linear with an S-S-S angle of 170.96(2)˚. Thus, the Fe4S3 core 
shows D2d symmetry, as displayed in the two renderings of the core given in Figure IV-
A B 
Figure IV-3. XRD structure of complex 1 with thermal ellipsoids drawn at 50% 
probability (H atoms omitted) (A). Two different views of the FeS-NO core 
(omitting the trityl groups) showcase the D2d symmetry of the core (B). 
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3 B. However, the bulky trityl groups introduce some slight distortion from perfect D2d 
symmetry.  
The D2d symmetry represents a departure from the overall geometry observed for 
other sulfur-containing DNIC clusters. As reviewed by Holm and Lo, nitrosylated iron-
sulfur clusters adopt rhomic, cuboidal, cubane, prismane, and rhombic dodecahedral 
geometries.125 As opposed to being an iron-sulfur cluster derivative, 1 is better described 
as two RREs joined by an interstitial sulfide. To our knowledge, 1 is structurally unique.  
The transformation of a DNIC into an iron-sulfur containing species, 1, wherein 
one of the sulfurs is a sulfide, models a reaction and resulting product that could be 
present in the regeneration of iron-sulfur clusters from DNICs. As observed by Liaw et 
al., the anionic DNIC [(NO)2Fe(SEt)2]
- reacts with Ph3CSH to yield the sulfide bridged 
species [(NO)2Fe(μ-SEt)(μ-S)Fe(NO)2]- along with HCPh3 and half an equivalent of 
EtSSEt.126 This reaction is rationalized to occur via consecutive reductions of the 
Ph3CSH by one of the coordinated ethylthiolates of [(NO)2Fe(SEt)2]
- to produce the 
intermediate [(NO)2(SEt)Fe(μ-S)Fe(SEt)(NO)2]2-. Elimination of an ethylthiolate then 
yields the isolated product [(NO)2Fe(μ-SEt)(μ-S)Fe(NO)2]-. The same mixed 
sulfide/ethylthiolate RRE was formed in the reaction of the RRE [(NO)2Fe(μ-
SEt)2Fe(NO)2] with Ph3CSH, leading Liaw et al. to conclude that the coordinated 
ethylthiolates initiate sulfide release from Ph3CSNO.
126 
Based on the studies by Liaw, it is plausible to envision that the reaction of 
Ph3CSNO and Fe(CO)2(NO)2 first forms the RRE (2). The tritylthiolates then initiate 
sulfur release from an additional Ph3CSNO, forming 1. However, without NMR data to 
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identify the biproducts, a more convincing mechanism cannot be proposed. In any case, 
the insertion of a sulfide in this reaction is significant as illustration of a possible 
intermediate in the regeneration of iron-sulfur clusters from DNICs. 
Although not absolutely identical, the two [(NO)2Fe(μ-SCPh3)Fe(NO)2] units are 
very similar. Table IV-1 lists the important metric parameters, reported in each case as 
an average. For each of the parameters shown, the deviation for the given parameters is 
very small, with the exception of the N-Fe-N angles.  
 
 
 
 
 
 
 
Table IV-1. Key metric parameters for 1, given as 
averages. 
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These angles range from 110.5(1)˚ to 115.3(1)˚, although comparison of the two 
halves show that each half contains one smaller and one larger N-Fe-N angle (110.5(1)˚ 
and 114.2(1)˚ for one half, and 112.5(1)˚ and 115.3(1)˚ for the other). The Fe-Fe, Fe-S, 
and S-S bond lengths are nearly identical to those found in the typical RREs such as SEt-
RRE and SPh-RRE. However, the S-C bond length of 1.930(2) Å is appreciably longer 
than the standard S-C bond length of 1.82 Å. With these rather weak S-C bonds, it is 
reasonable for this bond to be readily cleaved, leading to the formation of the bridging 
sulfide. 
There are slight differences in the Fe-N-O angles in 1 and those given for 
Roussin’s red esters with ethylthiolate (SEt-RRE) and phenylthiolate (SPh-RRE).126 The 
Fe-N-O angle of 1 (166.5(2)˚) is slightly smaller than the same angle in SEt-RRE 
(168.4˚) and SPh-RRE (169.95˚).126 Likely, the interstitial sulfide is the influencing 
factor here. For example, when both bridging sulfurs are sulfides, as in [Fe(-
S)2(NO)2]2, the Fe-N-O angle is significantly more bent (163.2(6)).
126  
As shown in Figure IV-1 (a), 1 can also be synthesized by addition of a THF 
solution of trityl thiol to freshly prepared Fe(CO)2(NO)2. The solution color and NO IR 
bands are identical to that seen in the reaction with Ph3CSNO and Fe(CO)2(NO)2. As 
would be expected in this case however, NO was not a concomitant product.  
When the -accepting CO ligands of the Fe(CO)2(NO)2 are replaced with the 
better donor ligand neocuproine (neo), and then the resulting DNIC, [(neo)Fe(NO)2], is 
reacted with Ph3CSNO, a mixture of 1 and the RRE, 2 are obtained, as shown in Figure 
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IV-1(c). Formation of NO was confirmed by trapping with [Fe(bme-daco)]2 using the 
same setup as given in Figure IV-2 B.  
 
 
 
 
 
 
 
 
The NO IR bands of the dark red product solution appeared at 1787 (sh), 1780, 
and 1747 cm-1 (blue spectrum, Figure IV-3). The two main bands at 1780 and 1747 cm-1 
are similar in pattern and separation (NO = 33 cm-1) to that of a typical RRE.21 Indeed, 
product isolation by washing with hexanes to remove 1 resulted in spectroscopically 
pure 2 (green spectrum, Figure IV-4). Like 1, 2 is stable for weeks under an inert 
atmosphere and at -35˚C. However, its stability under other conditions has not been 
tested.  
1 and 2: 1787 (sh), 1780, 1747 cm-1 
          1: 1787, 1752 cm-1  
          2: 1779, 1748 cm-1 
Wavenumbers (cm-1) 
Figure IV-4. Overlay of IR spectra, NO region, of the product mixture from the 
reaction given in Figure IV-1(c) (blue) with 1 (red) and 2 (green), show that a 
mixture of 1 and 2 are formed in this reaction. All spectra were recorded in DCM. 
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X-ray quality dark red crystals of 2 were obtained by slow evaporation of a 
concentrated DCM solution of 2 at -35˚C. As expected from the IR spectrum, 2 is 
composed of two Fe(NO)2 units bridged by two trityl thiolates in the typical RRE 
arrangement (Figure IV-4).  
 
 
 
 
 
 
 
 
The bridging thiolates and the two nitrosyl groups define a slightly distorted 
tetrahedral geometry for each iron center. All metric parameters listed in the table in 
Figure IV-5 are nearly identical to those parameters seen in 1 and they align well with 
what is expected for a typical RRE.21 The only difference between 1 and 2 significant 
enough to mention is the N-Fe-N angle whose average differs by ~ 2˚, i.e., 113.1(1)˚ for 
1 and 111.87(7)˚ for 2. 
Figure IV-5. Key metric parameters of 2 are given in the table. On the right is the 
XRD structure of 2 with thermal ellipsoids drawn at 50% probability (H atoms 
omitted). 
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14NO/15NO Exchange 
For the reactions discussed above, the NO that is released during the reaction can 
derive from either the RSNO or the DNIC. In order to confirm the source of the NO, the 
Ph3CSNO was prepared with the nitrogen labeled as 
15N via a synthetic route adopted 
from Connelly et al.89 The spectra of both 1 and the Fe(bme-daco)NO (within the outer 
tube in Figure IV-1B) from the reaction with Ph3CS
15NO is given in Figure IV-6.90 
 
 
 
 
 
 
 
 
The IR spectrum of 1 thus prepared from N-15 labeled RSNO showed three 
distinct stretching frequencies, wherein the two bands at 1787 and 1752 cm-1 correspond 
to the unlabeled 1. A third band at 1720 cm-1 matches very closely to the calculated 
A B 
Wavenumbers (cm-1) 
Figure IV-6. Overlay of the IR spectra, NO region, of 1 from reaction with trityl-
S15NO (blue) and 1 from the unlabeled reaction (red) (A). The spectrum of the 
[Fe(bme-daco)NO] after the reaction with trityl-S15NO shows the stretch for the 
unlabeled product (1648 cm-1) and the labeled product (1618 cm-1) (B). Both the 
DNIC (blue spectrum in A) and the mononitrosyl (spectrum B) show a mixture of 
labeled and unlabeled NO products. 
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value of 1718 cm-1 for one of the 15N nitrosyl stretches. The second band, which is 
expected to appear at 1741 cm-1, is buried beneath the other bands, hence the broad base 
of the peaks. Some of the 15NO was also incorporated into the [Fe(bme-daco)NO] as 
shown in Figure IV-5 B. The main stretch at 1648 cm-1 arises from the unlabeled 
[Fe(bme-daco)NO], while the second stretch at 1618 cm-1 corresponds exactly to the 
calculated value for [Fe(bme-daco)15NO]. Thus, we see extensive exchange of the NOs 
within this system.  
Conclusions 
We reported the synthesis and structural characterization of two new sulfur-
containing DNIC species. Complex 1 was isolated as a unique cluster of D2d symmetry 
containing an interstitial sulfide. It is tempting to posit that structures of this type might 
form in the regeneration of iron-sulfur clusters from DNICs. As a hybrid RRE/iron-
sulfur cluster of sorts, it is not farfetched to expect such as a possible intermediate in the 
iron-sulfur cluster repair process. A regular RRE containing tritylthiolates was also 
isolated and showed great similarity to other RREs. Finally, NO exchange between the 
nitrosyls of the Ph3CS
15NO and the Fe(CO)2(NO)2 was observed in the formation of 1. 
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CHAPTER V  
TOWARD BIOCOMPATIBLE DINITROSYL IRON COMPLEXES: SUGAR-
APPENDED THIOLATES*1 
 
Introduction 
The discovery of the therapeutic potential of nitric oxide and the existence of 
dinitrosyl iron complexes (DNICs) in biological systems have led to extensive 
biomimetic synthesis in this area.21,94 However, only a few studies have focused on the 
development of synthetic DNICs that are compatible with cell uptake studies. Notably, 
Vanin et al. have reported DNICs with natural thiol ligands (cysteine or glutathione), 
that display a variety of therapeutic responses including prolonged hypotension, 
attenuated platelet and erythrocyte aggregation, and promotion of skin wound healing; 
the glutathione DNIC is currently in clinical trials.48 Liaw et al. recently reported a water 
soluble neutral {Fe(NO)2}
9 DNIC that induced apoptosis in three different cancer cell 
lines.127 Earlier work by Liaw et al. described biological activity of dimeric Roussin’s 
Red Ester (RRE), [Fe(μ-SC2H4COOH)(NO)2]2 and monomeric DNIC, [(PPh2(Ph-3-
SO3Na))2Fe(NO)2], bearing –COOH and –SO3 functionalities for improved water 
solubility.104 Certain RRE and derivatized RREs also show photochemical NO release, 
as investigated by Ford et al.128 Kim et al. reported NO release from a 
(TMEDA)Fe(NO)2 complex, both within and outside a cellular environment.
45  
                                                 
*Reproduced in part from “Toward biocompatible dinitrosyl iron complexes: sugar-appended 
thiolates” Pulukkody, R.; Chupik, R. B.; Montalvo, S. K.; Khan, S.; Bhuvanesh, N.; Lim, S.-M.; 
Darensbourg, M. Y. Chem. Commun., 2017, 53, 1180-1183. Copyright 2017 by The Royal 
Society of Chemistry. 
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We have explored a new class of N-heterocyclic carbene (NHC)-bearing DNICs 
and trinitrosyl iron complexes, TNICs, and noted the potential of such derivatives to 
serve as a source of NO to biologically relevant NO-trapping agents such as iron or 
cobalt porphyrins, albeit in organic solvents and in the absence of air.22,95 Such 
limitations highlight the need for strategies to improve the water solubility and air 
stability of these compounds if meaningful translation into useful pharmaceuticals is to 
become reality. In the current study, we take advantage of the stability imparted by the 
lipophilic NHC on the (L)(X)Fe(NO)2 scaffold and employ a thiosugar as the anionic X 
ligand to improve hydrophilicity and biocompatibility.  
There is ample precedent for sugar-bound metal complexes in biomedical 
applications, ranging from contrast agents to therapeutics.129,130 Saccharides and their 
derivatives are naturally involved in many intracellular processes, acting as energy 
sources and involved in recognition processes.131 The use of sugars and their derivatives 
as ligands conjugated to metal complexes therefore presents opportunities to improve 
targeting properties that utilize the natural mechanisms of the cell for sugar uptake. For 
example, cellular internalization through lipophilic diffusion or via the membrane-bound 
glucose transporter, GLUT 1, of imaging agents containing 99mTc(I), 55Co(II) and Ga(III) 
bound to glucose-based ligands has been reported.130 The tunability of saccharide 
ligands themselves provides essential control over the lipophilicity and stability of 
metal-based drugs. Several carbohydrate-metal complexes, including platinum 
derivatives, have been studied for anticancer properties.129  
Most notably, the sugar-based, gold-containing drug, Auranofin, [(2,3,4,6-tetra-
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O-acetyl-1-thio-β-D-glucopyranosato-S)(triethyl-phosphine)]-gold(I), is currently used 
in the treatment of rheumatoid arthritis.132 As a monomeric, neutral gold compound, it is 
lipophilic and administered orally.132 A number of Auranofin derivatives have also been 
synthesized, and current work is directed towards testing these compounds for anticancer 
properties.133  
Results and Discussion 
Inspired by Auranofin, we synthesized and characterized examples of ‘sugar 
appended’ monomeric and dimeric DNICs. We have conducted preliminary in situ NO-
release studies of these complexes to both NO trapping agents and endothelial cells. 
Such compounds that combine the therapeutic properties of NO with the cell-attracting 
properties of a glucose moiety are amongst the few examples, to our knowledge, of 
DNICs with bio-functionalized ligands.  
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Figure V-1 presents the synthetic routes to the two main compounds of this 
study, the sugar-appended DNIC 1, and the sugar-appended RRE, 2, where R = 
(C=O)CH3. The NHC-stabilized trinitrosyl iron complex, IMes-TNIC, 
[(IMes)Fe(NO)3]
+,91 was used as a precursor for the synthesis of the oxidized, 
{Fe(NO)2}
9 complex 1, Figure V-1.  
 
Figure V-1. Synthesis of complexes 1 and 2; R = (C=O)CH3. 
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Reaction of [(IMes)Fe(NO)3]
+ with 1-thio-β-D-glucosetetraacetate in 1:1 
stoichiometric ratio (THF solution) results in a color change from green to brown within 
time of mixing. The shifts in the positions and pattern of the NO IR bands accompanying 
this color change in THF solutions, indicate the conversion of the TNIC to 1, with 
concomitant release of NO gas, Figure V-2A.91 Complex 1 showed the classic isotropic 
EPR signal for S = ½, oxidized {Fe(NO)2}
9 DNICs at g = 2.03, R. T. (Figure V-2B).21 
When exposed to air in the solid state, 1 remained visibly unchanged for ca. 2 h; solid 1 
was stable over several weeks under an inert atmosphere. In THF and DMSO solutions, 
and under N2, no degradation was obvious over ca. 36 h. On exposure of these solutions 
to air, however, major changes to the IR spectrum were seen within 1 h, Figure V-3. X-
ray quality red colored crystals of 1 were obtained from hexane/THF diffusion under an 
inert atmosphere. The molecular structure of 1 is shown in Figure V-4, and important 
metric parameters are listed in supporting information. 
A C B 
Figure V-2. (A) (NO) region IR spectrum overlay of 1 (brown), IMes-TNIC 
(green) and free 1-thio-β-D-glucosetetraacetate (dashed); (B) EPR spectrum of 1 
at R.T.; (C)  (NO) region IR spectrum of 2. All spectra recorded in THF. 
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The molecule maintains the pseudo-tetrahedral geometry seen in all previously 
reported NHC-DNICs.21,94 The planes of the mesitylenes are roughly perpendicular to 
the CN2C2 plane, providing an ‘umbrella’ to the (RS)Fe(NO)2 trigonal base. 
 
 
 
 
 
 
B A 
Figure V-3. IR spectra of (A) complex 1 in DMSO upon exposure to air for 3 h: 
ν(NO) 1663 cm-1 and (B) complex 3 in THF (green), after 30 min in DMSO and air 
(red) and after 16 h DMSO and air (blue). The same species at 1665 cm-1 appears here 
as well.  
Figure V-4. XRD structure of complex 1 with thermal ellipsoids drawn at 
50% probability (H atoms omitted). 
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The NO ligands are slightly bent with average Fe-N-O of 170.8°; they adopt the 
well-known “attracto” conformation,134 bending in towards each other as defined by 
smaller O-Fe-O compared to N-Fe-N, in the co-planar FeN2O2 unit.  All other metric 
parameters are similar to the prototypic analog of this compound, (IMes)(SPh)Fe(NO)2 
(3).91 However, a structural overlay of 1 and 3 along the Fe-Ccarb bonds displays a twist 
of ca. 30˚ in the orientation of the IMes ligand, which positions the phenyl ring of the 
IMes in closer proximity to the glucose in 1 than it is to the SPh in 3 (Figure V-5). 
Deprotection of the sugar thiol ligand in compound 1 was achieved by reaction 
with excess NaOMe in MeOH, Figure V-6. The identity of the deprotected product (1′) 
was verified by direct synthesis via an alternate route as described in the Chapter II.  
Complex 1’ was less stable than the protected analogue, with THF solution lifetime of 
only several hours even under inert atmosphere.  
 
Figure V-5. Overlay of Complex 1 (green) and Complex 3 (blue). The acetyl 
groups on the thioglucose have been omitted for clarity. 
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The dimeric (µ-RS)2[Fe(NO)2]2 form of 1 was synthesized by the known method 
for other RRE analogues135 (Figure V-1, counterclockwise reaction); i.e., addition of 1-
thio-β-D-glucosetetraacetate to freshly prepared Fe(CO)2(NO)2 (in THF) in 1:1 
stoichiometric ratio. The reaction was complete in about 12 h, at 22 °C and the resulting 
(µ-RS)2[Fe(NO)2]2 complex 2, bearing acetylated thio-glucose units, could be verified 
by the corresponding IR shift and pattern shown in Figure V-2C. A brown solid was 
obtained upon recrystallization of the THF solution of 2 with hexanes and characterized 
by ESI mass spectrum signals at m/z = 959 [M + H]+  and  980 [M + Na]+. As expected 
for the dinuclear, spin-paired [{Fe(NO)2}
9−{Fe-(NO)2}9] DNICs, this compound was 
EPR silent in both THF and DCM solutions, but not DMSO, vide infra. 
In contrast to 1, 2 showed notably improved stability in air. It was stable in air 
for 2 days even in solution, increasing to several months under inert atmosphere in the 
solid state. As with 1, 2 was also completely soluble in DMSO, a commonly used 
solvent for administering pro-drugs in cell studies. However, similar to the observation 
Figure V-6. IR spectrum of complex 1′ in THF: ν(NO) 1768 (sh), 1716 cm-1. 
Dotted-line inset: IR spectrum of complex 1 (THF). 
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of Liaw et al. for the N-acetyl-D-penicillamine (NAP)-containing dinuclear DNIC, [(-
S-NAP)2Fe(NO)2]2, upon dissolving 2 in DMSO, a dynamic interconversion occurs 
between 2 and another {Fe(NO)2}
9 DNIC.136 The NO and C(O)O IR bands shift slightly 
from 1786, 1759, and 1749 (sh) cm-1 (THF) to 1785, 1754, and 1744 (sh) cm-1 (DMSO). 
Additionally, in DMSO, a rhombic EPR signal (gx = 2.043, gy = 2.030, gz = 2.013) 
appears, which may be ascribed to the S = ½ species [(S-pGlu)(DMSO)Fe(NO)2] (Figure 
V-7). Vacuum removal of the DMSO (even after one week of stirring) followed by 
addition of either THF or DCM recovers diamagnetic 2.  
 
 
 
 
 
 
 
Previous studies by Hess et al. on the NO release ability of the prototypic NHC-
DNICs suggested that oxidized, {Fe(NO)2}
9 DNICs are better sources of NO in the 
Figure V-7. (a) Overlay of the X-band EPR spectrum of complex 2 in DMSO 
solution (red) with complex 2 in DMSO and media (blue) at 295 K. (b) Overlay of 
X-band EPR spectrum of 2 in DMSO and media (red) and that of the simulated 
spectrum (blue dotted line 
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presence of NO trapping agents when compared to the reduced {Fe(NO)2}
10 
analogues.22,128 In fact, these oxidized NHC-DNICs ([(NHC)2Fe(NO)2]
+) were seen to 
release NO very rapidly (within minutes) to the cobalt porphyrin-derived NO  trapping 
agent provided in situ.22 To qualitatively probe the ability of the sugar-derivatized 
DNICs to release or transfer NO, 1 was combined with 2 equiv of the NO-trapping 
reagent Co(TPP) (Co(TPP) = 5,10,15,20-tetraphenyl-21H,23H-porphine cobalt(II)) in 
THF solution at 22°C. Over ca. 48 h, a steady decrease in intensity of the NO bands of 1 
was observed. Poor resolution in this spectrum necessitated product separation. Upon 
addition of MeOH, the product mixture produced a purple residue; the isolated purple 
solid showed an IR band at 1683 cm-1 in DCM, indicating the formation of 
(TPP)Co(NO).38,137 This suggests oxidative nitrosylation of Co(II)TPP by the released 
NO radical.38 To augment this study, an alternate NO trapping agent was used. 
A host of MN2S2 complexes have been well characterized, containing a variety of 
transition metal ions such as FeII, NiII, PdII, CoII, CuII, and ZnII with various N2S2 
ligands.79 Iron and cobalt N2S2 complexes where N2S2 = bme-dach (N,N′-bis(2- 
mercaptoethyl)-1,4-diazacycloheptane), or bme-daco (N,N′-bis(2-mercaptoethyl)-1,4-
diazacyclooctane), form penta-coordinate, dimeric  [N2S2M]2 units which are readily 
cleaved by  NO, producing N2S2M(NO),  M = Fe and Co.
92,138 The [(bme-dach)Fe]2 was 
successfully used as an NO-trapping agent by Hsieh et al. in “double-tube” experiments, 
where an NHC-TNIC, such as that shown in Scheme V-1 (placed in the inner tube), on 
addition of PhS-, released NO as free NO radical/gas, trapped as (bme-dach)Fe(NO) in 
the outer tube.91 The cobalt analogue is equally efficient as a trapping agent. 
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Based on such precedents, and the availability of these NO trapping agents, 1 and 
2 were separately reacted with excess [(bme-dach)Co]2 in DCM solutions to test for 
release or transfer of NO, which would subsequently be trapped in the form of the 
monomeric (bme-dach)Co(NO). For 1, the NO IR bands disappeared over the course of 
48 h, indicating loss of NO from 1. Complex 2 showed loss of NO bands in about 24 h. 
Upon solvent removal and washing of the brown residue with diethyl ether, the resulting 
IR spectrum of the residue taken up in DCM (Figure V-8 inset) showed a strong, broad 
signal at 1601 cm-1, assigned to the νNO of (bme-dach)Co(NO).38 A second IR band at 
1754 cm-1 (1747 (sh)) can be assigned to the (Me-C(O)O)  of the acetylated thio-sugar 
unit. The exact identity of this species is unclear.  
To quantify the NO transferred in these reactions, 1 and 2 were again reacted 
with [(bme-dach)Co]2 in DCM, but both reactions were stopped at 24 h (to correlate with 
the timescale used in the Griess analysis vide infra). Using the intensities of the νNO of 
(bme-dach)Co(NO) and a calibration curve (Figure V-8), 1 was found to form 0.5 mols 
Co(bme-dach)NO per mol 1, while 2 formed 2.7 mols Co(bme-dach)NO per mol 2. The 
poor NO transfer from 1 is most likely due to the robust nature of 1, as a portion of 1 
remains unreacted after 24 h. Although the efficiency of [Co(bme-dach)]2 at NO uptake 
is not known with certainty, these studies correlate well with the results from the Griess 
assay described below. Overall, the results provide evidence for the release/transfer of 
NO from 1 and 2 in the presence of NO trapping agents. 
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The promising results from the NO release chemical studies outlined above, in 
conjunction with both the considerable air stability and DMSO solubility of these 
compounds, prompted us to investigate the behavior of these DNICs in a biological 
environment. It is well established that the tetraacetylthioglucose ligand in Auranofin 
undergoes a ligand exchange reaction with cysteine-34 in serum albumin.133 Thus, it is 
reasonable to postulate that 1 and 2 might undergo a similar exchange, a possibility that 
gains further credence according to the work by Bello et al.64 Therein, a diglutathionyl 
1550165017501850
Wavenumbers (cm-1)
y = 11x + 0.0025 
 R2 = 0.9934  
Figure V-8. Plot of the intensity of the NO vs. concentration of Co(bme-dach)NO for 
concentrations ranging from 3-14 mM. This plot was used to calculate the moles of 
NO transferred from 1 and 2 following a 24-h stir of either 1 or 2 with [Co(bme-
dach)]2 in DCM. For 1, 0.5 moles of the Co(bme-dach)NO were formed per mole of 
complex, while for 2, 2.7 moles of the Co(bme-dach)NO were formed per mole of 
complex. Inset: IR spectrum resulting from complete reaction of 1 or 2 with [(bme-
dach)Co]2 in THF: ν(NO) 1601 cm-1 indicates the formation of (bme-dach)Co(NO).   
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DNIC was shown to bind to human glutathione transferase via exchange of one of the 
DNIC glutathione ligands for the tyrosine of the active site.64 Furthermore, the 
interconversion between 2 and its DMSO adduct (presumably [(S-
pGlu)(DMSO)Fe(NO)2]), demonstrates the reactivity of the Fe-S bond. For exploration 
of the effect of the sugar appendages on the DNIC, we have enlisted two other 
complexes for comparison with 1 and 2. Complex 3, which contains the dinitrosyl iron 
unit in the oxidized {Fe(NO)2}
9 state, is structurally analogous to 1, differing by X = 
SPh. Complex 4 is a reduced {Fe(NO)2}
10 DNIC containing the 2, 9-dimethyl-1,10-
phenanthroline ligand, and provides a comparison with a DNIC containing both a very 
different ligand set and a different redox level. Complex 1’ was not explored in this 
study due to its instability.  
The four compounds under consideration, namely 1, 2, 3, and 4, were first 
assessed for their potential cytotoxicity toward endothelial cells. Bovine coronary 
venular endothelial cells (CVECs) were exposed to various concentrations of each 
compound (0.01 –100 µM) and screened for % viability using the MTS assay 
(colorimetric sensitive method for quantification of viable cells). Both 1 and 2 show an 
increase in cell proliferation prior to a sharp decrease in viability (IC50 of 31 M and 68 
M for 1 and 2, respectively, Figure V-9 A). 
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The IC50 values determined for 1 and 2 are similar to those reported by Liaw et 
al. for other DNICs.104,127 The unusual increase in proliferation may be attributed to the 
effect of the thiosugar moiety itself, as the control experiment demonstrates a three-fold 
increase in proliferation over the same concentration range, Figure V-9 B. The sharp 
decrease in proliferation at higher concentrations of 1 and 2 (>IC50) may thus be 
attributed to the damage inflicted on the cells by the DNICs, presumably from the 
generation of free NO, which ultimately results in complete cell death. Data from the 
second control experiment is also shown in Figure V-9 B in the form of the effect of 
NaNO2 on cell proliferation; no significant effect is observed. The influence of the 
glucosylated thiol on the cell viability in 1 is particularly apparent when compared to the 
viability assay results of the analogous DNIC, 3 (Figure V-10 A). Replacement of the 
Figure V-9. In vitro cell viability of CVEC cells upon 72 h incubation with 1 and 2 
(A) and the thiosugar (green) and sodium nitrite (purple) controls (B) at 
concentrations between 0.01 and 100 M. 
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glucosylated thiol with the thiophenylate causes a dramatic increase in the cytotoxicity, 
resulting in an IC50 of 7.3 µM for 3 compared to 31 µM for 1.  
 
 
 
 
 
 
 
 
Complex 4, with an IC50 of 21 µM (Figure V-10 B), is slightly more toxic than 
either of the sugar derivatives, but still falls in the range of acceptable toxicity levels for 
potential pro-drugs. Based on results from similar studies, it is reasonable to conclude 
that the cell death in each case occurred via apoptosis.48,104,127  
To quantify the amount of NO produced by 1-4, the commonly used Griess assay 
was employed; results are displayed in Figure V-11. In this assay, the conversion of NO 
to nitrite (NO2
-) in aqueous solutions is monitored by reaction of the NO2
- with sulfanilic  
Figure V-10. Cell viability vs. concentration of complex for 3 (A) and 4 (B). Each 
sample was diluted by a dilution factor of 2. There were ca. 12 ranges of 
concentrations (high – low) and each concentration was done in a set of triplets. Each 
dot on the plot represents the average of the three readings at that specific 
concentration.  
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acid to form a diazonium salt, which is then detected by the azo dye, N-(1-
naphthyl)ethylenediamine dihydrochloride. In the absence of cells, this assay suggests 
that 1, 2, and 4 released appreciable amounts of NO to the aqueous medium (Figure V-
11). Complex 4 exhibited rapid NO release reaching a plateau after 0.5 h. This maximum 
approaches 2 µM NO for 1 µM of 4. The NO to 4 stoichiometric ratio of nearly 2:1, was 
relatively consistent across all three concentrations tested. We conclude that the oxygen 
sensitivity of 4 (which is in the reduced {Fe(NO)2}
10 state) activates it towards NO 
 
Figure V-11. Griess assay results for addition of 1 (A), 2 (B), 3 (C), and 4 (D) at 
concentrations of 0.3 M (blue), 1 M (red) and 3 M (green) to the medium 
without cells. Total nitrite concentration correlates to the NO concentration. 
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release. 
Complex 2, being of the RRE-type, can theoretically deliver 4 equiv of NO per 
molecule. As seen in Figure V-11 B, 2 shows a slight increase in NO release over a 24 h 
period, reaching a maximum of 3.5 µM NO for 3 µM of 2 at 24 h. The much slower NO-
release rate of 2 as compared to 4 highlights the stability of 2 and its potential to serve as 
a slow-release pro-drug. In a long term study, 2 showed a steady release of NO up to 7 d. 
Complex 1 proved to be a much poorer NO-release agent, yielding a maximum of 1 
equiv of NO per molecule at 2 h (Figure V-11 A). Complex 3 did not show appreciable 
amounts of NO released over the course of 24 h. The results seen for 1 and 3 reflect their 
behavior when exposed to oxygen (Figure V-3). As monitored by IR, the NO bands of 1 
and 3 decrease concomitant with the growth of a new peak at 1664 cm-1 in both cases 
(presumably a mononitrosyl species). We conclude that this contributes to poor results 
seen from the Griess Assay. When the Griess assay was performed in the presence of 
cells (Figures V-12), the observed difference in nitrite concentration (Figures V-13) as 
compared to that in the absence of cells indicated the prospect of NO uptake by the cells, 
for all four DNICs.  However, the margin of error was too great to draw definitive 
conclusions.  
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Figure V-12. Griess assay results for addition of 1 (A), 2 (B), 3 (C), and 4 (D) to 
the medium in presence of cells at concentrations of 0.3 M (blue), 1 M (red) 
and 3 M (except for 3 (C), where 0.03, 0.1 and 0.3 M concentrations were 
used due to high cytotoxicity). Total nitrite concentration correlates to the NO 
concentration.  
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Conclusions 
In conclusion, the first sugar-appended iron dinitrosyl complexes were 
synthesized and characterized. Qualitative NO release studies in the presence of NO-
trapping agents derived from porphyrins or Co(N2S2) complexes demonstrated the 
ability of these compounds to transfer NO and nitrosylate Co(II). Additionally, both 1 
and 2 released NO to cell media, both in the presence and absence of cells. In particular, 
Figure V-13. Differential of NO release to media with and without cells for 
complexes 1-4, A-D, respectively. Negative nitrite concentrations are 
indicative of cellular uptake of NO. The values were calculated by 
subtracting the amount of nitrite in the media alone (NOM) from that found in 
the presence of cells (NOCM). 
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the long term release of NO displayed by 2 makes it a prime candidate for further 
exploration as a potential therapeutic agent. The synthetic protocol discussed herein 
shows that the strategy of glycoconjugation of DNICs holds potential for extension to 
the attachment of other carbohydrate units already in use as targeting ligands in drug 
delivery.  
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CHAPTER VI  
STRUCTURAL COMPARISONS OF DNICS INVOLVING MN2S2 AND 
PHOSPHINE LIGANDS 
 
Introduction 
In the preceding chapters, the Fe(NO)2 unit has been explored in its capacity to 
be stabilized by a variety of C-, N- and S-donor ligands, and for its degradation to 
release NO under certain conditions. There is also a rather extensive synthetic enterprise 
developed primarily by the M. Y. Darensbourg laboratory, that examines the binding of 
the Fe(NO)2 unit to N2S2 metalloligands.
79 These cis-dithiolato-metalloligands are 
inspired by natural Cys-X-Cys tripeptide motifs that utilize the deprotonated amido 
nitrogens and the cysteinyl sulfurs to form a roughly square planar N2S2 binding pocket. 
Such a motif is realized in the active sites of nitrile and thiocyanate hydratase, binding 
Fe and Co, although the difference in the hydratases is that in each the sulfurs are 
oxygenated.139 The acetyl-CoA synthase active site also contains this binding motif and 
houses a nickel in the N2S2 binding pocket. In this case, the NiN2S2 metalloligand binds 
a second nickel center through the two thiolates of the metalloligand.  
The electronic properties of these biomimetic MN2S2 metalloligands, where M = 
Ni, Fe(NO), and Co(NO), have been probed via the formation of stable W(CO)4 
adducts.92 The carbonyls, as well as the nitrosyls for the Fe(NO) and Co(NO) cases, 
provide spectroscopic handles to rank the electron-donating ability of the metalloligands. 
The NiN2S2 is a slightly better donor than the Fe(NO) and Co(NO) metalloligands; this 
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result is consistent with the greater electron-withdrawing ability of {Co(NO)}8 and 
{Fe(NO)}7 on the bridging thiolate sulfurs.92 However, discrimination between the 
electronic properties of the various nickel complexes with different N2S2 ligands was not 
possible using the W(CO)4 reporter; the resulting structures are largely the same, and 
transfer of electron density towards the tungsten and passed on via π-backbonding to the 
CO’s is not distinguished.92 Other receiver units have since been utilized, for example 
the (η5-C5H5)Fe(L)+ unit readily binds the MN2S2 metalloligands in the formation of 
M(µ-SR)2Fe heterobimetallics.
140 As another iron source, the Fe(NO)2 unit binds in its 
two redox levels and is largely the focus of this dissertation. 
Perhaps more intriguing than the electronic properties of these metallo-
dithiolates-M’ complexes was the host of binding modes and geometries possible and 
adopted in well-characterized complexes.79 The dinitrosyliron unit, Fe(NO)2, acts as a 
Lewis acid fragment to the MN2S2 and is isolable in both oxidized, {Fe(NO)2}
9, and 
reduced, {Fe(NO)2}
10 forms.79 Pohl et al., have shown that the reduced {Fe(NO)2}
10 
form may be isolated with neutral NiN2S2 (N2S2 = N,N’-diethyl-3,7-diazanonane-1,9-
dithiolate, i.e. an “open chain” ligand) as the stabilizing ligand in which the NiN2S2 is 
bidentate bound to the iron of the Fe(NO)2 forming a butterfly structure analogous to the 
W(CO)4 derivatives.
141 In contrast, when (μ-I)2[Fe(NO)2]2, used as a source of 
{Fe(NO)2}
9, reacts with bis-mercaptoethanediazacyclooctane nickel, [(bme-daco)Ni], in 
a 2:1 ratio, the NiN2S2 metalloligand binds two units of Fe(NO)2I on opposite sides of 
the NiN2S2 plane in a transoid fashion (vide infra).
142 The M. Y. Darensbourg group has 
prepared multiple (MN2S2)Fe(NO)2 biomimetic complexes, M = Ni
II, {Fe(NO)}7, 
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{Co(NO)}8, and (V≡O)2+, some of which are my own; these will be discussed in this 
chapter.79  
 
 
 
 
 
 
 
 
We also note the various coordination modes of the metalloligands, i.e. 
monodentate through one thiolate, bidentate to one metal center, or each thiolate bound 
Figure VI-1. Chemdraw representations of complexes 1-6, each of which will be 
discussed in this chapter.  
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to a different metal center, finding similarities and differences with modes seen with 
phosphine ligands. This chapter will include examples of phosphine-DNICs that exhibit 
the similar binding arrangements to those of the metallodithiolato ligands. The crystal 
data and structure refinement information for 1-5 are provided at the end of the chapter.  
[Ni (bme-daco)Fe(NO)2] (1) 
Synthesis  
Fe(CO)2(NO)2 was freshly prepared from the reaction of sodium 
tetrafluoroborate (0.012 g, 0.10 mmol) and [Na-18-crown- 6-ether][Fe(CO)3(NO)] 
(0.046 g, 0.10 mmol) in THF. Under a nitrogen atmosphere, a THF solution of Ni(bme-
daco) (0.029 g, 0.10 mmol) was added to the freshly prepared Fe(CO)2(NO)2 and the 
mixture was stirred for 1 h at room temperature. Complete disappearance of the (CO) 
bands and a red shift of the (NO) IR bands confirmed the formation of 1. Solvent 
removal in vacuo resulted in the degradation of the unstable product. Dark red crystals 
suitable for X-ray crystallographic studies were obtained by slow diffusion of a 
hexanes/diethyl ether mixture into a concentrated THF solution of 1 at -35˚C.  IR (THF, 
cm-1): (NO) 1677(s), 1630(vs). The instability of the complex rendered other 
characterization impossible. 
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Structural Analysis  
Similar to the report of Pohl et al.,141 but incorporating a different N2S2 ligand, 
namely N,N′-bis (2-mercaptoethyl)- 1,4-diazacyclooctane (bme-daco), the author, in 
collaboration with former group member Chung-Hung Hsieh, synthesized a reduced 
Ni(bme-daco)Fe(NO)2 (1) from addition of a THF solution of Ni(bme-daco) to a freshly 
prepared THF solution of Fe(CO)2(NO)2. The structure of 1, which adopts a classic 
butterfly core, is given in Figure VI-2. An analogous butterfly structure, Ni(bme-dach) 
(bme-dach = N,N′-bis (2-mercaptoethyl)-1,4-diazacycloheptane) was synthesized in a 
similar manner and reported by the M. Y. Darensbourg group.70 Some key parameters of 
1 are given in Table VI-1, along with comparative parameters from the Ni(bme-
dach)Fe(NO)2 and the Ni(N2S2)Fe(NO)2 open chain complex isolated by Pohl et al.
70,141 
The Ni-Fe distance of 3.001(2) Å in 1 falls between the other two analogous 
Ni(N2S2)Fe(NO)2 complexes, as seen in Table VI-1.  
 
Figure VI-2. Ball and stick representation of complex 1. 
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With the increasing rigidity of the N2S2 backbone (i.e. less flexibility), 
undoubtedly affecting the optimal orientation of the S lone pairs that converge on the 
second metal, the Ni-Fe bond length increases. The notable elongation of ca. 0.2 Å in 
going from the open chain ligand to bme-daco to bme-dach in implies a role for carbon 
linkers between the nitrogens in the N2S2 backbone. The Fe-N-O angles in 1 are slightly 
bent toward each other and are very similar to those seen in other similar complexes. 
The (NO) IR stretches of 1 correlate well with the angles obtained and again fall in the 
middle between the bme-dach and open chain analogs. 
Table VI-1. Selected bond lengths (Å) and bond angles (˚) for complex 1 compared 
to those parameters in the analogous bme-dach and Ni(N2S2)Fe(NO)2 (*) “open 
chain” (synthesized by Pohl et al).70,141 
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[Ni (bme-daco)Fe(NO)2(IMes)]2[BF4]2 (2) 
Synthesis 
Under an argon atmosphere, Ni(bme-daco) (0.029 g, 0.10 mmol), a purple solid, 
and [(IMes)Fe(NO)3][BF4]  (0.054 g, 0.10 mmol), a green solid, were loaded into a 
Schlenk flask and dissolved in CH2Cl2 (20 mL). The resulting dark red solution was 
stirred for 2 h at room temperature and monitored by IR spectroscopy to insure complete 
conversion to product. Solvent was then reduced to a minimum in vacuo, followed by 
addition of hexanes to precipitate the dark maroon product. The solid product was then 
washed with a mixture of hexanes and diethyl ether (3 x 20 mL) to remove impurities 
and residual volatiles were removed in vacuo. After again dissolving in CH2Cl2, the 
product was filtered through Celite to remove any insoluble solids. Dark maroon 
crystals, suitable for X-ray crystallographic studies, were obtained by slow diffusion of a 
hexanes/diethyl ether mixture into a concentrated CH2Cl2 solution of 2 at -35
˚C.  IR 
(CH2Cl2, cm
-1): (NO) 1793(s), 1734(vs). Elem. Anal. Calc. for 
C62H88B2F8Fe2N12Ni2O6S4: C, 45.73; H, 5.45; N, 10.32. Found: C, 46.63; H, 5.59; N, 
10.50. +ESI-MS (CH2Cl2) m/z = 710.1942 for [Ni (bme-daco)Fe(NO)2(IMes)]2
2+. 
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Structural Analysis  
Complex 2 represents a rare example of a pentacoordinate Ni2+ that is distorted 
toward trigonal bipyramidal geometry with τ = 0.31. Each Fe(NO)2 unit is in the 
oxidized {Fe(NO)2}
9 state. The two Ni2+ ions are separated by 3.326(1) Å and are each 
coordinated by the two nitrogens and the two thiolates of the N2S2 ring as well as a fifth 
thiolate that binds to the nickel center from a second N2S2 metalloligand (Figure VI-3). 
The distance between each nickel center and the sulfur of the bridging thiolate is 2.3714 
(14) Å. The bridging Ni-S distance is only slightly longer than the Ni-S distances within 
the N2S2 plane (avg. 2.3524(15) Å).  
Figure VI-3. Ball and stick representation of complex 2. 
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For the Fe(NO)2 units, the Fe-N and N-O bond distances are typical of that seen 
in other {Fe(NO)2}
9 DNICs with similar ligand sets.79 The average Fe-N and N-O bond 
lengths, 1.672(5)Å and 1.181(6) Å, respectively, are essentially identical to the average 
Fe-N and N-O bond distances in the cobalt analog (complex 4) (1.675(6) Å and 1.171(7) 
Å) and in IMesFe(NO)2SPh (1.672(3) Å and 1.184(3) Å).
93 All the other main distances 
and angles for the IMesFe(NO)2 unit also match nearly perfectly with those of 
IMesFe(NO)2SPh. Thus the thiolate of the Ni(bme-daco) bound to the Fe in 2 can be 
considered very similar to the thiolate of phenylthiolate.  
The similarities between the structures of this nickel dimer and the corresponding 
iron and zinc analogs are truly remarkable, as displayed by the overlays in Figure VI-
4.79,143 The M2S2 diamond core in complex 2 (defined by Ni(1)-S(2)-Ni(2)-S(3) with Ni-
S-Ni angles equal to 89.95o) is a nearly precise match to that of analogous iron (Figure 
VI-4 (a)) and zinc cores (Figure VI-4 (b)).79,143  
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Thus, it appears that the two DNIC units present in complex 2 act as sufficiently 
strong electron withdrawing groups to result in the electron density at each nickel 
becoming more like that of iron or zinc. This decrease in the electron density is then 
compensated by the binding of a third sulfur to each nickel. Hence, the nickel deviates 
from its preferred square planar geometry and becomes pentacoordinate to gain extra 
stability via electron donation from the sulfur.  
Cyclic Voltammetry (CV)  
The cyclic voltammogram of 2 (Figure VI-5 A) shows one main quasi-reversible 
event at E1/2 = - 1.03 V, assigned to the {Fe(NO)2}
9/10 redox couple. The assignment is 
made based on comparison with other similar complexes.144 While the reduced analogs, 
such as 1,  show an electrochemical response to added acid, addition of HBF4 to 2 
Figure VI-4. Overlay of 1 (gold) with [Fe(bme-daco)]2 (a) and [Zn(bme-daco)]2 (b). 
The Fe and Zn dimers are shown in Chemdraw form next to each overlay.79,143 
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caused a distinct shift in the redox event at E1/2 = - 1.03 V to E1/2 = - 0.77 V indicative of 
the formation of a new species.  
 
 
 
 
 
 
 
IR analysis of the solution from the electrochemical cell following acid addition 
is shown in green in Figure VI-6, overlaid with the IR spectrum of 2 (blue). We propose 
that the acid protonates one of the thiolate sulfurs, which weakens the Ni-S bonds and 
causes the cleavage of the dimer (reaction scheme in Figure VI-6). The resulting species 
is then a monomeric derivative of Ni(bme-daco) in which one of the thiolates is 
protonated while the other remains bound to the Fe(NO)2 unit. 
Figure VI-5. Cyclic voltammogram of 2 shown as a full scan at 200 mV/s (A). 
Overlay of the CV scan of 2 in DCM (blue) and of 2 after addition of 1 equiv. of 
HBF4 (red). 
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Figure VI-6. IR spectrum, (NO) region, of 2 in DCM (blue) ((NO): 1793, 1733 cm-1) 
and the DCM solution of 2 from the electrochemical studies following addition of ca. 3 
equiv. of HBF4 (green) ((NO): 1817, 1732 cm-1). 
 
 
 
In summary, complex 2 is a unique example not only structurally, in that it 
adopts a rare penta-coordinate geometry about each nickel center, but also in its 
reactivity toward acids. Both the shift in the IR spectrum and in the CV indicate the 
formation of a new species, which we assign as a monomer. Studies are ongoing to 
identify this presumed monomeric species. One method that can be imployed to identify 
this product structurally is to use triphenylphosphine gold(I) as a surrogate for the 
proton. Thus far, we have not been able to obtain our proposed monomer with one of the 
thiolates bound to gold and the other to the Fe(NO)2. Rather, the Ni(bme-daco) typically 
falls out and binds the gold, forming a stair-step structure where two Ni(bme-daco) units 
are bridged by two AuI ions, similar to that described in the next section.  
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[{Ni(bme-daco)}2Au2]2+(Cl2Fe(NO)2)2- (3) 
Synthesis  
Complex 1 was prepared using a 0.10 mmol scale as described earlier in this 
chapter. To the freshly prepared THF solution of 1 was added a THF solution of 
AuPPh3Cl (0.049 g, 0.10 mmol). Following a 1 h stir, the IR spectrum revealed complete 
conversion to the product. The solvent was removed in vacuo and the resulting dark red 
solid was washed with hexanes (3 x 5 mL). The product solid was then redissolved in 
DCM, filtered through Celite to remove any insoluble solids, and solution volume was 
reduced to a minimum. X-ray quality crystals were obtained by slow diffusion of a 
hexanes/diethyl ether mixture into such a concentrated CH2Cl2 solution of 3 at -35
˚C.  IR 
(CH2Cl2, cm
-1): (NO) 1673(s), 1625(s).  
Structural Analysis 
The cationic species [(Ni(bme-daco))2Au2]
2+ has been reported by the M. Y. 
Darensbourg group, albeit with chlorides as the counterions.142 The metric parameters of 
the [(Ni(bme-daco))2Au2]
2+ isolated with the DNIC counteranion (3) are nearly identical 
to those reported previously.142 A significant difference here is the formation of a rare 
[Cl2Fe(NO)2]
2- species as the counteranion.  
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The structure of 3 is given in Figure VI-7 and key metric parameters of 
[Cl2Fe(NO)2]
2- are listed in the table below the structure. Halide-containing DNICs, 
[Br2Fe(NO)2]
- (reported and discussed in Chapter III) and [I2Fe(NO)2]
- 114 in which the 
countercations are sodium 18-crown-6 ethers, were obtained as monoanions. The 
monoanionic [Cl2Fe(NO)2]
- has been utilized in many DNIC reactions, but has never 
been structurally characterized. To our knowledge, no dianionic DNIC of this type has 
been reported. Interestingly, the Fe-N and N-O distances of 3 are nearly identical to 
Figure VI-7. Ball and stick representation of complex 3. Bond lengths (Å) and 
bond angles (˚) for the counteranion, [Cl2Fe(NO)2]2- are given in the table. 
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those of other halide DNICs.114 The Fe-Cl bonds are ca. 0.2 Å shorter than the average 
Fe-I bonds in [I2Fe(NO)2]
- but are nearly identical to the Fe-Br bond lengths in 
[Br2Fe(NO)2]
-.  
The notable difference comes in the Fe-N-O angles. The average Fe-N-O angle is 
165.9(6)˚ for [Br2Fe(NO)2]- and 164.9(3)˚ for [I2Fe(NO)2]-; for 3, the average is 
159.6(4)˚.114 The significantly more bent Fe-N-O angles coupled with the lack of any 
additional anionic species in the crystal structure, supports the assignment of 
[Cl2Fe(NO)2]
2- as a dianionic species. Liaw et al., reported the only other dianionic, 
four-coordinate {Fe(NO)2}
10 DNIC: [(EtS)2Fe(NO)2]
2-, which contains two potassium 
18-crown-6 ethers as countercations.26 Each of the thiolates of [(EtS)2Fe(NO)2]
2- sits 
3.328 Å away from a potassium, close enough for S…K interaction that is likely 
necessary to stabilize the dianionic species. In a similar manner, one of the chlorides in 3 
is positioned at 3.333(1) Å from one of the gold centers, allowing for Cl-…AuI 
interaction and stabilization of the dianion.  
[(NO)Co(bme-dach)(IMes)Fe(NO)2](BF4) (4)*2 
Synthesis 
The trinitrosyl iron complex [(IMes)Fe(NO)3][BF4] (0.11 g, 0.20 mmol) (where 
IMes = the N-heterocyclic carbene of 1,3-bis(2,4,6-trimethylphenyl)imidazole) and 
[Co(bme-dach)]2 (0.056 g, 0.10 mmol) were loaded in a degassed 50 mL Schlenk flask, 
septum sealed, and 10 mL CH2Cl2 solvent were added by syringe. The reaction mixture 
                                                 
*Reproduced in part from “Dinitrosyl iron adducts of (N2S2) M (NO) complexes (M= Fe, Co) as 
metallodithiolate ligands” by Hsieh, C. H.; Chupik, R. B.; Pinder, T. A.; Darensbourg, M. Y.  
Polyhedron 2013, 58, 151–155. Copyright 2012 by Elsevier Ltd. 
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was stirred for 1 h; its IR spectrum (CH2Cl2 solution) indicated complete conversion to 
product. The solution was filtered through Celite to remove insoluble solid. Addition of 
pentane to the CH2Cl2 solution yielded a dark brown precipitate, which was washed by 
diethyl ether (3 x 20 mL) to remove impurities (Yield: 0.099 g, 61%). Recrystallization 
in CH2Cl2/pentane-diethyl ether at 35˚C afforded crystals of complex 4 suitable for X-
ray crystallographic study. IR (CH2Cl2), cm
-1: (NO): 1794 (s), 1735 (vs), 1622(m). 
Elem. Anal. Calc. for C30H42CoFeN7O3S2BF4: C, 44.24; H, 5.20; N, 12.04. Found: C, 
44.37; H, 5.08; N, 12.69%. + ESI-MS (CH2Cl2) m/z = 727.1138 for [(NO)Co(bme-
dach)(IMes)Fe(NO)2] 
+ . 
 
 
 
 
 
 
 
 
Structural Analysis  
Crystals of complex 4 as its BF4 salt were obtained as described above. Selected 
distances and angles are in Table VI-2. The structure of complex 4 (see Figure VI-7), 
Figure VI-8. Ball and stick representation of complex 4. 
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shows the (bme-dach)Co(NO) unit bound to the Fe(NO)2 unit through a single bridging 
thiolate. This positions the Fe at 3.697 Å from the Co, with the Co–Fe–S angle at 
108.6(2)˚. The nitrogen and sulfur donors define a square plane about the cobalt with 
deviation from best N2S2 plane in the range of 0.011–0.014 Å. 
 
 
 
 
 
 
 
 
The cobalt is displaced from the N2S2 best plane by 0.38 Å, which is an increase 
of 0.074 Å from the 0.306 Å displacement seen in the free (bme-dach)Co(NO) ligand. 
The Co–N–O angle of 128.5˚ is 5˚ larger than that found in (bme-dach)Fe(NO), 123.8˚ 
[8]. Thus the coordination geometry about cobalt is little changed from that of the free 
metallodithiolate ligand. The Fe center in complex 4 retains its tetrahedral environment 
with the carbene, bridging thiolate, and two nitrosyls, both bound in a slightly bent 
fashion, as shown by the bond angles given in Table VI-2. The N–Fe–N angle is 
119.6(3)˚ and the Fe–N–O bond angles are 168.2(5)˚ and 172.6(6)˚. There are no other 
Table VI-2. Selected bond lengths (Å) and bond angles (˚) for complex 4. 
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significant differences between the appropriate portions of the precursors to the 
heterobimetallic and the adduct itself.  
[(Dmpe)Fe(NO)2] (5) (Dmpe = 1,2-Bis(Dimethylphosphino)Ethane) 
Synthesis 
Under an argon atmosphere, dmpe (33 mL, 0.20 mmol) was added to a THF 
solution of (IMes)(SPh)Fe(NO)2 (prepared according to published procedure).
91  
Following a 2 h stir, the solution turned from the deep purple starting material to a red 
brown. IR spectroscopy confirmed complete conversion to complex 5. Solvent was 
removed in vacuo and the solid product washed with hexanes (2 x 10 mL). Solid 5 was 
redissolved in ether and filtered through Celite to remove any insoluble impurities. X-ray 
quality crystals were obtained by slow evaporation of a concentrated ether solution of 5 
at -35˚C. IR (THF, cm-1): (NO): 1699 (s), 1658 (vs).  
 
 
 
 
 
Figure VI-9. ORTEP drawing of complex 5 with thermal ellipsoids at 50 % 
probability level. Selected bond lengths (Å) and bond angles (˚) for 5 are given in the 
table. 
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Structural Analysis  
The crystals of 5 were grown by Randara Pulukkody and the solved structure was 
given to the author for analysis and further investigation. The structure contains a 
pseudotetrahedral iron center coordinated by the phosphorous atoms of a single dmpe 
ligand and the two nitrosyl nitrogens (Figure VI-9). The Fe-N, N-O and Fe-P bond 
lengths align well with values reported for other phosphorous-containing DNICs.145 
Although the Fe-N-O angle for 5 is on the high end (Fe-N-O angle range for neutral, 
{Fe(NO)2}
10 ca. 166-178˚, considering S-, N-, O- and C-donar ligands) the 
bis(phosphine) DNICs generally have larger Fe-N-O angles.21,145  
Unlike the majority of DNICs isolated to date, the nitrosyls are oriented away 
from each other in the rare “repulso” conformation. The “repulso” conformation is 
defined by an O-Fe-O angle that is greater than the N-Fe-N angle. In 5, the O-Fe-O 
angle is 143.76˚ while the N-Fe-N angle is 139.16˚. This conformation is more typical of 
second and third row transition metal nitrosyls, for example the neutral M(NO)2(PPh3)2, 
where M = Ru, Os, and the cationic species [M(NO)2(PPh3)2]
+, where M = Ir, Rh.145-151 
To our knowledge, the only DNICs with the “repulse” conformation reported were two 
bisphosphine DNICs, where the bisphosphine was either 1,2-
bis(diphenylphosphino)benzene or cis-1,2-bis(diphenyllphosphino)ethylene.145 The 
authors attributed the rare conformation of the nitrosyls to electronic effects due to the 
C=C  bonds within the ligand.145 Although 5 does not contain any C=C bonds, the 
dmpe ligand is strongly donating into the N-O bonds as seen from extremely low (NO) 
IR stretching frequencies 1699, 1658 cm-1. 
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-(Dppe)[Fe(NO)2]2} (6) (Dppe = 1,2-Bis(Diphenylphosphino)Ethane) 
Synthesis  
Under a nitrogen atmosphere, a THF solution of dppe (0.040 g, 0.10 mmol) was 
added to a THF solution of Fe(CO)2(NO)2 (freshly prepared from the reaction of sodium 
tetrafluoroborate (0.012 g, 0.10 mmol) and [Na-18-crown- 6-ether][Fe(CO)3(NO)] 
(0.046 g, 0.10 mmol)). The mixture was stirred for 1 h at room temperature. Complete 
disappearance of one of the (CO) bands, and a red shift in both the (NO) bands and 
the remaining (CO) band confirmed the formation of 6. Solvent was removed in vacuo 
and the dark brown product residue was redissolved in hexanes and filtered through 
Celite. X-ray quality crystals were obtained from slow evaporation of the concentrated 
hexanes solution of 6 at -35˚C. IR (THF, cm-1): (NO): 1764 (s), 1723 (vs); (CO): 2008 
(s).  
Structural Analysis  
Crystals of complex 6 were obtained as described above. Though the crystals 
were not of sufficient quality to obtain publishable data, a structure was obtained and is 
given in Figure VI-10. We highlight this structure to illustrate the ability of the phophine 
ligand to serve as a spanning ligand. Complex 5 demonstrated the well-known ability of 
the bis-phosphine to serve as a bidentate ligand to the Fe(NO)2 unit, paralleling the 
binding seen in complex 1 in which the Ni(bme-daco) is bound in a bidentate fashion to 
the Fe(NO)2.
152,153,157 
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In a similar manner, the MN2S2 ligands can also serve as spanning ligands in 
which the metallodithiolate binds two different metal centers, one through each thiolate 
sulfur. Two examples are shown in Figure VI-11. The [Ni(bme-dach)·(W(CO)5)2] 
structure (Figure VI-11 A) was obtained by group member Pokhraj Ghosh (unpublished) 
and the [Ni(bme-daco)·(Fe(NO)2I)2] (Figure VI-11 B) was reported by the M. Y. 
Darensbourg laboratory in 2014.142 
 
 
 
Figure VI-10. ORTEP drawing of complex 6 with thermal ellipsoids at 50 % 
probability level. 
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Summary and Conclusions 
Although some of the structures presented are similar to others reported in the 
literature, there are also some presented herein that contain rarely seen and rather unique 
structural properties. Complex 2 is one of only a handful of five-coordinate nickel 
complexes.154-156 Additionally, with one of the thiolates of the bme-daco binding the iron 
of the DNIC unit and the other thiolate binding the nickel center of a separate Ni(bme-
daco), 2 becomes nearly geometrically identical to the [Fe(bme-daco)]2 and the 
[Zn(bme-daco)]2, suggesting that the nickel center in this coordination environment 
behaves more like Fe or Zn.79,143  
The counteranion in 3, being the dianionic species [Cl2Fe(NO)2]
2- is the lone 
example of a dianionic halide-containing DNIC. As was shown, the Fe-N-O angles are 
significantly more bent, indicative of increased electron density on the nitrosyls. The 
Figure VI-11. Ball and stick representation of [Ni(bme-dach)·(W(CO)5)2] (left) and 
[Ni(bme-daco)·(Fe(NO)2I)2] (right) each of which display the NiN2S2 acting as a 
spanning ligand, similar to what is seen with the posphines.  
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only other dianionic, four-coordinate, monomeric {Fe(NO)2}
10 DNIC reported to date is 
[(EtS)2Fe(NO)2]
2-, which is stabilized by two potassium 18-crown-6 ether cations.26 
Both of the phospine DNICs presented in this chapter are also worth 
highlighting. Complex 5 houses the nitrosyls in the rather rare “repulso” configuration, 
only reported in a couple of other phosphine DNICs, as well as second and third row 
transition metal nitrosyls.145-151 Though there are many examples of bisphosphines acting 
as spanning ligands,152,153,157 complex 6 represents the only example of a bisphosphine 
spanning two different Fe(NO)2 units.  
Finally, comparison of the M(N2S2) and phosphine structures presented within 
this chapter showcase the similarities between the two ligands in regards to binding 
modes towards the Fe(NO)2 unit. For example, both 1 (containing the Ni(bme-daco)) 
and 5 (with dmpe) present bidentate binding of the ligand to a single Fe(NO)2 unit. In 
both 2 and 3, the Ni(bme-daco) spans two different metal centers, in a manner similar to 
dppe in 6, which spans between two different Fe(NO)2 units. However, while each 
phosporous has only one lone pair, each thiolate sulfur contains two lone pairs. Because 
each of these lone pairs is oriented in a different direction, an array of binding 
orientations is possible between the metallodithiolate ligands and the Fe(NO)2 unit. The 
contrast in binding modes displayed in 1 and 3 illustrates this point well. In 1, the 
convergent lone pairs are utilized, resulting in bidentate binding of the Fe(NO)2 while 
the divergent lone pairs remaining on each sulfur create the butterfly structure. In 3, the 
divergent lone pairs are involved, each binding a separate AuI ion to yield the stairstep 
structure.  
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Crystallographic Data 
Table VI-3.  Crystal data and structure refinement for [Ni (bme-daco)Fe(NO)2] (1). 
Identification code  feni 
Empirical formula  C10.50 H21 Cl Fe N4 Ni O2 S2 
Formula weight  449.44 
Temperature  110(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C 2/c 
Unit cell dimensions a = 12.318(8) Å = 90°. 
 b = 11.116(7) Å = 90.062(7)°. 
 c = 24.241(15) Å  = 90°. 
Volume 3319(4) Å3 
Z 8 
Density (calculated) 1.799 Mg/m3 
Absorption coefficient 2.429 mm-1 
F(000) 1848 
Crystal size 0.400 x 0.200 x 0.050 mm3 
Theta range for data collection 2.468 to 29.638°. 
Index ranges -16<=h<=16, -15<=k<=15, -33<=l<=33 
Reflections collected 20288 
Independent reflections 4376 [R(int) = 0.0487] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7459 and 0.6617 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4376 / 0 / 195 
Goodness-of-fit on F2 1.085 
Final R indices [I>2sigma(I)] R1 = 0.0314, wR2 = 0.0671 
R indices (all data) R1 = 0.0437, wR2 = 0.0708 
Extinction coefficient n/a 
Largest diff. peak and hole 0.809 and -0.733 e.Å-3 
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Table VI-4.  Crystal data and structure refinement for Ni(daco)Fe(NO)2IMes (2). 
Identification code  Ni(daco)Fe(NO)2IMes 
Empirical formula  C62 H88 B2 F8 Fe2 N12 Ni2 O4 S4 
Formula weight  1596.42 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 18.764(2) Å = 90°. 
 b = 19.612(3) Å = 90.044(2)°. 
 c = 19.820(3) Å  = 90°. 
Volume 7294.0(16) Å3 
Z 4 
Density (calculated) 1.454 Mg/m3 
Absorption coefficient 1.086 mm-1 
F(000) 3320 
Crystal size 0.16 x 0.11 x 0.06 mm3 
Theta range for data collection 1.09 to 22.96°. 
Index ranges -20<=h<=20, -21<=k<=21, -21<=l<=21 
Reflections collected 73449 
Independent reflections 8396 [R(int) = 0.1235] 
Completeness to theta = 22.96° 83.0 %  
Absorption correction None 
Max. and min. transmission 0.9377 and 0.8454 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8396 / 0 / 877 
Goodness-of-fit on F2 0.940 
Final R indices [I >2sigma(I)] R1 = 0.0410, wR2 = 0.0957 
R indices (all data) R1 = 0.0744, wR2 = 0.1143 
Largest diff. peak and hole 0.539 and -0.434 e.Å-3 
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Table VI-5.  Crystal data and structure refinement for [{Ni(bme-
daco)}2Au2]
2+(Cl2Fe(NO)2)
2- (3). 
Identification code  [{Ni(bme-daco)}2Au2]
2+(Cl2Fe(NO)2)
2- 
Empirical formula  C11 H22 Au Cl4 Fe N4 Ni O2 S2 
Formula weight  759.77 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 11.0317(3) Å = 90°. 
 b = 14.2453(4) Å = 
104.5580(10)°. 
 c = 14.0475(3) Å  = 90°. 
Volume 2136.69(10) Å3 
Z 4 
Density (calculated) 2.362 Mg/m3 
Absorption coefficient 25.622 mm-1 
F(000) 1460 
Crystal size 0.200 x 0.050 x 0.020 mm3 
Theta range for data collection 4.495 to 65.147°. 
Index ranges -12<=h<=12, -16<=k<=16, -16<=l<=16 
Reflections collected 23192 
Independent reflections 3642 [R(int) = 0.0553] 
Completeness to theta = 65.147° 100.0 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3642 / 60 / 230 
Goodness-of-fit on F2 1.054 
Final R indices [I>2sigma(I)] R1 = 0.0274, wR2 = 0.0611 
R indices (all data) R1 = 0.0318, wR2 = 0.0629 
Extinction coefficient 0.00036(2) 
Largest diff. peak and hole 1.918 and -1.760 e.Å-3 
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Table VI-6. Crystal data and structure refinement for [(NO)Co(bme-dach)(IMes)Fe(NO)2][BF4] 
(4). 
Identification code  datax 
Empirical formula  C31 H44 B Cl2 Co F4 Fe N7 O3 S2 
Formula weight  899.34 
Temperature  110(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 20.372(9) Å = 90°. 
 b = 7.966(4) Å = 94.387(18)°. 
 c = 24.785(10) Å  = 90°. 
Volume 4010(3) Å3 
Z 4 
Density (calculated) 1.490 Mg/m3 
Absorption coefficient 1.072 mm-1 
F(000) 1852 
Crystal size 0.10 x 0.08 x 0.02 mm3 
Theta range for data collection 1.25 to 25.00°. 
Index ranges -24<=h<=24, -6<=k<=9, -29<=l<=20 
Reflections collected 19398 
Independent reflections 7039 [R(int) = 0.1060] 
Completeness to theta = 25.00° 99.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9789 and 0.9003 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7039 / 0 / 475 
Goodness-of-fit on F2 1.010 
Final R indices [I>2sigma(I)] R1 = 0.0685, wR2 = 0.1674 
R indices (all data) R1 = 0.1359, wR2 = 0.2094 
Largest diff. peak and hole 2.001 and -0.668 e.Å-3 
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Table VI-7.  Crystal data and structure refinement for [(dmpe)Fe(NO)2] (5). 
 
Identification code  dmpe 
Empirical formula  C6 H16 Fe N2 O2 P2 
Formula weight  266.00 
Temperature  150.15 K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C 1 2/c 1 
Unit cell dimensions a = 9.460(3) Å = 90°. 
 b = 10.947(3) Å = 111.478(3)°. 
 c = 12.118(3) Å  = 90°. 
Volume 1167.7(5) Å3 
Z 4 
Density (calculated) 1.513 Mg/m3 
Absorption coefficient 1.539 mm-1 
F(000) 552 
Crystal size 0.08 x 0.05 x 0.02 mm3 
Theta range for data collection 2.969 to 27.523°. 
Index ranges -12<=h<=12, -14<=k<=14, -15<=l<=15 
Reflections collected 6496 
Independent reflections 1342 [R(int) = 0.0426] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7456 and 0.6336 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1342 / 0 / 62 
Goodness-of-fit on F2 1.038 
Final R indices [I>2sigma(I)] R1 = 0.0257, wR2 = 0.0574 
R indices (all data) R1 = 0.0352, wR2 = 0.0605 
Extinction coefficient n/a 
Largest diff. peak and hole 0.472 and -0.247 e.Å-3 
  
145 
 
 
CHAPTER VII  
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Through advances in synthetic and spectroscopic methodologies and the 
combined efforts of inorganic and biochemists, the fundamental chemistry of the 
biologically recognized nitric oxide storage and transport agents, dinitrosyl iron 
complexes (DNICs), has been firmly established.21,94,95 With such advances in this field, 
the development of DNICs into meaningful pharmaceuticals can finally be realized. 
Inspired by such a potential, the work reported in this dissertation was focused on 
addressing the little explored area of DNIC reactivity with components of cellular 
environments. The reactivity studies recognized the DNIC/Copper/RSNO connections 
and their interwoven chemistry regarding NO release, and explored structural studies of 
aggregates of DNICs with metallodithiolates. Design strategies for NO-release 
therapeutic development of DNICs were also presented. 
As discussed in Chapter I, very few studies within the field of DNIC chemistry 
have been devoted to understanding NO release from DNICs. Most simply assess the 
ability of the DNIC to transfer NO in the presence of an NO acceptor, such as an iron or 
cobalt porphyrins.22,41,45 Such studies however, fail to address other plausible modes of 
NO release, specifically what effect other components of the cellular environment would 
have on DNICs. Work by Liaw et al.represents a single example of exploring such 
interactions, and demonstrated that addition of various chelating agents to a carbazolate 
DNIC resulted in release of NO as NO+, NO., or NO-, depending upon the incoming 
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ligand.42 Considering that the other biological NO carrier, S-nitrosothiol (RSNO), 
requires copper to catalyze the release of NO,52-55 we were surprised that copper had not 
been considered as a player in NO release from DNICs. Chapter III described our 
investigation of copper promoted NO release from DNICs. Addition of CuI and CuII salts 
to solutions of the reduced, {Fe(NO)2}
10 DNIC [(neo)Fe(NO)2], where neo = 2,9-
dimethyl-1,10-phenanthroline (neocuproine), resulted in the transfer of the neocuproine 
ligand to Cu and concomitant release of NO. Such results open the door to many 
possibilities, most important of which is triggered NO release. 
One of the challenges in the development of DNICs as pharmaceuticals is control 
of the delivery of NO. As pioneered by Ford et al., one of the strategies for solving this 
issue is through light-activated NO release.36,37 Photo-activation, while attractive, is 
limited to more topical applications. More promising strategies would involve working 
with the natural cellular components and mechanisms. Our study with copper provides 
one such approach. Considering that copper is an important cofactor in many cellular 
metalloenzymes and thus prevalent within the cell, it is reasonable to suggest that 
cellular copper species might play a role in NO release from DNICs.158 As Chapter III 
has only laid the basic foundation for copper-promoted NO release from DNICs, future 
studies should build on these results by employing more biologically relevant DNICs 
and copper sources. Possible copper sources could include copper complexes of 
histidine, cysteine or glutathione, all of which have been previously reported and mimic 
endogenous copper sources.159-162 Such copper complexes, coupled with DNICs such as 
the thiosugar-DNICs discussed in Chapter V, would provide a realistic biomimetic study 
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for the effect of copper on NO release from DNICs. Although both the thiosugar-DNICs 
presented in Chapter V did release NO in the aqueous media, neither released its full 
nitrosyl payload, even after 24 h. If copper proves to be effective in promoting full NO 
release from these DNICs or if it enhances the rate of NO release, a two component drug 
formulation could be created wherein the copper and DNIC are only allowed to mix at 
the target site. We note that copper in any significant concentrations would be cytotoxic. 
Hence a detailed analysis of the concentration ranges of copper that would be effective 
in promoting NO release should be performed. 
In collaboration with Dr. Soon-Mi Lim at Texas A&M University, we are 
currently investigating the effect of copper on these sugar DNICs through live imaging 
of smooth muscle cells. Smooth muscle cells do not produce NO, but rather respond to 
added NO by relaxing. The efficacy of the DNIC both with and without Cu can then be 
assessed through confocal microscopy by visualizing the cellular relaxation. 
The idea of using components of the cell to yield pharmacologically active 
species is not a new one. The activity of the anti-cancer agent cis-platin also relies upon 
the differences in intra- and extracellular chloride concentration.46 Since the intracellular 
chloride ion concentration is significantly lower than the extracellular concentration, 
cisplatin loses both chloride ions upon entering the cell, at which point it becomes 
active.46 Kim et al. also utilized such a method with a five-coordinate, iodide-containing 
DNIC, which was discussed in Chapter I.45 Upon loss of the iodide, a metastable, four-
coordinate DNIC is formed, which spontaneously decomposes to release NO. Hence, it 
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was proposed that the labile iodide would dissociate upon entering the cell, thus forming 
the NO-releasing four-coordinate DNIC only after entering the cell.45 
Another finding presented in Chapter III that merits further study is the 
correlation between the redox levels of both the DNIC and the copper regarding NO 
release, i.e. does CuII work better for the reduced {Fe(NO)2}
10 DNICs while CuI is more 
effective for the oxidized {Fe(NO)2}
9 DNICs? For the reduced DNIC [(neo)Fe(NO)2] 
employed in our study, this was the case. Although addition of both CuI and CuII resulted 
in NO release from [(neo)Fe(NO)2], the Cu
II reaction occurred within minutes, while the 
CuI reaction time was on the order of hours. Ideally, a DNIC that is stable in both redox 
levels should be used to test this hypothesis. One such possibility is [(Ar-
nacnac)Fe(NO)2] (Ar-nacnac = anion of [(2,6-diisopropylphenyl)NC(Me)]2CH), which 
was developed by Lippard et al. and isolated in both redox levels.41 All four 
combinations, namely Cu(I)/{Fe(NO)2}
10, Cu(II)/{Fe(NO)2}
10, Cu(I)/{Fe(NO)2}
9 and 
Cu(II)/{Fe(NO)2}
9 could then be analyzed using the same ligand set.  
The interconnection between copper and DNICs, discussed in both Chapters I 
and III, was also demonstrated in the interaction of DNICs with another cellular 
component, S-nitrosothiols (RSNOs). Drawing inspiration from the work of Vanin et 
al.,18,59 that claims DNICs, as well as Cu, can promote NO release from RSNOs, Chapter 
IV described the reactivity of the trityl-S-nitrosothiol with two reduced {Fe(NO)2}
10 
DNICs of the form [(L)2Fe(NO)2] (L = CO or neo). In both cases, NO was released, 
which agreed with the findings of Vanin et al. that DNICs promote NO release from 
RSNOs.18,59 However, labeling studies showed complete scrambling of the nitrosyls.  
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A more interesting result presented in Chapter IV was the formation of a unique 
(-S)(SR)2[Fe(NO)2]4 cluster. This cluster is particularly intriguing in that it contains an 
interstitial sulfide. Although tritylthiol is a known sulfide donor,126 the formation of a 
sulfide-containing species from reaction of the two biological NO carries might point to 
an additional role for RSNOs, namely as possible sulfide donors in the repair mechanism 
of iron sulfur clusters. Although many FeS(NO) clusters have been isolated,125 the 
cluster reported here is structurally unique. Such a species can be viewed as a possible 
intermediate within the pathway of iron sulfur cluster repair. 
Further studies in this area could again be aimed at making a more biologically 
relevant system. Would the cluster still form if a different RSNO was used (where R = 
glutathione or cysteine)? Also, investigating this reaction using oxidized DNICs would 
be of interest, as such species are confirmed to exist endogenously (vid EPR 
spectroscopy).10-14 
Even with the impressive advances that have been made in DNIC chemistry, 
there is surprising lack of biologically viable DNICs available for development into 
pharmaceuticals. The main roadblock in this area is selecting ligands that are both 
biocompatible and provide sufficient stability to the Fe(NO)2 unit. Beyond these basic 
guidelines, ligands tagged with specific cell receptors for targeted delivery or improved 
cellular uptake, is an attractive possibility. The approach outlined in Chapter V 
employed glucose-based ligands in the form of acetylated thioglucose. The use of the 
thioglucose not only incorporates needed stability and enhanced biocompatibility, but it 
allows the potential to exploit the natural mechanisms of the cell for sugar uptake.130,131 
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The two thioglucose DNICs reported, one of the dimeric Roussin’s red ester form and 
the other a monomeric species containing both an N-heterocyclic carbene and the 
thioglucose, showed remarkable air stability and low cytotoxicity towards endothelial 
cells. Although neither DNIC released more than 50% of its NO payload, cellular uptake 
was observed.   
The release of NO from the thioglucose DNICs was measured indirectly using 
the Griess Assay, which measures the amount of nitrite produced via the formation of an 
azo dye. Furthermore, the measurements of the amount of NO taken up by the 
endothelial cells was calculated based on a difference measurement between the 
concentration of NO released in the presence of cells vs the NO concentration in the 
absence of cells. Such limitations leave one vital question unanswered: how does the NO 
release occur. Is the DNIC transported intact into the cell prior to NO release or is the 
NO released outside the cell and carried in via passive diffusion? Liaw, Vanin and others 
have probed cellular DNICs using EPR spectroscopy.44,47,104 The drawback to this 
technique is the extreme similarity of many of the signals produced by DNICs. Even if a 
signal is observed within the cell, such a signal could arise from the formation of a new 
DNIC upon entry of NO into the cell. A better method for tracking the fate of the DNIC 
would be through fluorescent tagging. 
Perhaps one of the most intriguing contributions to dinitrosyl iron chemistry in 
the past two decades has been the isolation of glutathione S-transferase (GST) with a 
dinitrosyl iron unit bound in the active site.64 Although none of the work presented in 
this dissertation involved GST, the important role it plays in DNIC chemistry merits 
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mention. Not only is this the first, and to date, the only protein-bound DNIC that has 
been structurally characterized, it is also another example of the correlation between 
copper and the Fe(NO)2 unit.  
As discussed in Chapter I, GST is an important part of cell detoxification. The 
GST accomplishes this detoxification by catalyzing the conjugation of glutathione to 
xenobiotic substrates, which include metal ions.73,74 Considering this mode of action 
coupled with the successful binding of the glutathione DNIC to the GST active site, the 
question arises as to whether non-glutathione DNICs (such as the thiosugar DNICs, for 
example) would still be taken up by GST. Such a study that would test GST uptake of 
DNICs containing various ligand sets, would inform on the fate of exogenously added, 
non-glutathione DNICs. It is also surprising that although copper strongly inhibits GST 
activity,60-63 no Cu-bound GST has been isolated to date. Such a structure would allow 
for further comparison between the electronically similar CuII/I and {Fe(NO)2}
9/10 
species and add to the already strong correlation between copper and DNICs. 
Chapter VI represents a departure from the much more biological focus of the 
other chapters. This structurally focused chapter, however, demonstrated a few of the 
diverse complexes that incorporate the Fe(NO)2 unit. Additionally, the metallodithiolate 
ligands, which mimic Cys-X-Cys tripeptide motifs, showcase the types of interactions 
such species might have the Fe(NO)2 unit.  
Overall, dinitrosyl iron chemistry is a fascinating field with great potential both 
chemically and medicinally. From the extensive possibilities for improved ligand design 
to further probing DNIC reactivity within a biological environment to better 
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understanding the mechanism of NO release much remains to be explored. The strides 
that have been made in this area position DNICs on the road to answering the need for 
safe NO-releasing pharmaceuticals. 
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